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Abstract 
Cancer Specific Stress and Insomnia Severity 
Among 
Breast Cancer Patients 
Jessica H. Wolfman, MA, MS 
Jacqueline D. Kloss, PhD  
 
 
 
 
Objective:  Living with cancer can lead to significant stress that impacts multiple 
dimensions of an individual’s life (Dunn et al., 2006).  Insomnia symptoms are one such 
adverse consequence of stress related to cancer (Palesh et al., 2006).  This is particularly 
apparent among individuals with breast cancer, with an estimated 37% to 63% endorsing 
symptoms of insomnia (Davidson, MacLean, Brundage, & Schulze, 2002, Fortner, 
Stepanski, Wang, Kasprowicz, & Durrence, 2002; Koopman, Nouriani, Erickson, 
Anupindi, Butler, Bachmann, et al., 2002; Savard, Simard, Blanchet, Ivers, & Morin, 
2001).  Many predisposing, precipitating, and perpetuating factors are likely to contribute 
to insomnia among individuals with breast cancer (Savard & Morin, 2001).  Additionally, 
mindfulness has been proposed as having an association with insomnia and related 
factors (Lundh, 2000).  In an attempt to develop a more in depth understanding of 
specific predisposing, precipitating, and perpetuating factors associated with insomnia 
among breast cancer patients, a survey study was conducted.  Methods:  Fifty six breast 
cancer patients receiving treatment at The Cancer Institute of New Jersey at Cooper 
University Hospital were recruited to participate in this survey study.  Results:  Forty 
eight percent of breast cancer patients reported a clinically significant level of insomnia 
symptoms.  A history of sleep difficulties was the only predisposing factor that accounted 
for a significant amount of variance in insomnia symptoms.  In reference to precipitating 
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factors, cancer specific stress contributed to the variance in insomnia symptoms above 
and beyond a history of sleep difficulties.  Dysfunctional beliefs and attitudes about sleep 
did not emerge as a significant perpetuating factor.  Mindfulness was not found to 
moderate relationships involving insomnia symptoms among breast cancer patients.  
Discussion:  Findings from the present study suggest that insomnia symptoms are 
prevalent among individuals with breast cancer.  In addition, specific predisposing 
(history of sleep difficulties) and precipitating (cancer specific stress) factors were found 
to predict insomnia symptoms among our sample.  Given that the relationship between 
cancer specific stress and insomnia symptoms among individuals with breast cancer is a 
novel finding, research should aim to confirm results and explore this unique relationship. 
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CHAPTER 1:  INTRODUCTION 
 
Cancer is a widespread health concern that affects millions of individuals in the 
United Stated (American Cancer Society, 2006).  Although a diagnosis of cancer was 
once synonymous with a grim prognosis, medical advances have allowed individuals to 
survive far beyond once held expectations.  As survivorship increases, more individuals 
are living with cancer, and therefore, living with the stress of cancer. Not surprisingly, 
cancer can significantly reduce an individual’s quality of life (QoL; Dunn et al., 2006).  
Individuals with cancer have higher levels of stress (Kreitler, Peleg, & Ehrenfeld, 2007), 
including the increase in stress that is specifically associated with cancer, such as the 
cancer diagnosis and treatments implemented to treat cancer.  In addition to cancer 
specific stress (Parker Baile, Moor, & Cohen, 2003), levels of general perceived stress 
(Kreitler et al., 2007), psychological variables such as depression and anxiety (Frick, 
Tyroller, & Panzer, 2006), and demographic variables such as age (Parker et al., 2003), 
have been associated with QoL among individuals with cancer.  Sleep quality has also 
been identified as a correlate of QoL among cancer patients, with several studies finding 
that individuals with cancer who reported poorer sleep quality were more likely to 
indicate poorer QoL (Fortner, Stepanski, Wang, Kasprowicz, & Durrence, 2002; for 
review, see Kvale & Shuster, 2006; Schubert et al., 2002).  Given this relationship, an 
understanding of insomnia and factors that contribute to sleep difficulties may aid in 
developing ways to understand and potentially improve the overall well-being of 
individuals with cancer.    
The well established relationship between compromised sleep and decreased QoL 
(Fortner et al., 2002; for review, see Kvale & Shuster, 2006; Mystakidou et al., 2007; 
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Schubert et al., 2002) further highlights the importance of investigating sleep among 
individuals with cancer.  In addition, the prevalence of insomnia (difficulty initiating 
sleep, maintaining sleep or nonrestorative sleep; DSM-IV-TR; American Psychiatric 
Association, 2000; Edinger et al., 2004) is higher among individuals with cancer, with an 
estimated 19% to 63% of individuals with cancer reporting insomnia or insomnia 
symptoms (for review, see Kvale & Shuster, 2006) compared to an estimated 30% to 
48% of the general population (Ohayon, 2002).  The prevalence of insomnia symptoms 
among individuals with breast cancer specifically is estimated to be 37% to 63% 
(Davidson, MacLean, Brundage, & Schulze, 2002; Fortner et al., 2002; Koopman et al., 
2002; Savard, Simard, Blanchet, Ivers, & Morin, 2001).  When Davidson and colleagues 
(2002) compared prevalence of insomnia symptoms by type of cancer, individuals with 
breast and lung cancer endorsed significantly more symptoms of insomnia relative to 
individuals with other forms of cancer.  Given that breast cancer is the most common 
non-skin cancer among women in the United States (Ries et al., 2008) and insomnia 
symptoms among individuals with breast cancer is prevalent (Davidson et al., 2002; 
Fortner et al., 2002; Koopman et al., 2002; Savard et al., 2001) an investigation into 
symptoms of insomnia among individuals with breast cancer is fitting.  However, only a 
few studies have systematically or empirically explored insomnia symptoms among 
individuals with breast cancer (Bardwell et al., 2006; Savard et al., 2001).   
In one theoretical article, Savard and Morin (2001) explored factors associated 
with insomnia among individuals with a variety of cancer types.  In order to 
conceptualize the psychological and physiological factors associated with the onset and 
maintenance of insomnia among individuals with cancer, Savard and Morin (2001) 
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utilized the three-factor model proposed by Spielman and colleagues (Spielman, Caruso, 
& Glovinsky, 1987; Spielman & Glovinsky, 1991).  This model was originally developed 
to provide a foundation for conceptualizing insomnia within the general population (for 
review, see Perlis, Jungquist, Smith, & Posner, 2005).  According to the three-factor 
model, predisposing factors are those that increase the likelihood of developing insomnia, 
such as gender, age, and psychological variables.  Precipitating factor(s), such as the 
stress associated with cancer, bring about an episode of insomnia.  Perpetuating factors 
such as dysfunctional beliefs and attitudes about sleep, maintain the insomnia.  The 
interplay of factors contributes to the development and maintenance of insomnia 
(Spielman et al., 1987; Spielman & Glovinsky, 1991).  For example, having a history of 
depression may predispose an individual to insomnia, stress associated with having breast 
cancer may precipitate an acute insomnia, and dysfunctional beliefs and attitudes about 
sleep may perpetuate insomnia, leading to a chronic condition.  Together, these factors 
create a cycle of dysfunction.  Savard and Morin (2001) applied the three-factor model 
developed by Spielman and colleagues (1987; 1991) to individuals with cancer, to better 
understand insomnia within this population.  Therefore, a better understanding of cancer 
specific stress is important in understanding insomnia, including symptoms of insomnia, 
within a breast cancer population.    Exploring which unique factors are associated with 
insomnia symptoms, may aid in developing a better understanding of insomnia among 
individuals with breast cancer. 
In addition to the three-factor model proposed by Spielman and colleagues 
(Spielman, Caruso, & Glovinsky, 1987; Spielman & Glovinsky, 1991), Lundh (2000; 
2005) presented a model of insomnia that includes aspects of mindfulness.   The concepts 
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of mindfulness, that is - when thoughts and experiences are brought into the present 
moment in a nonjudgmental fashion (Baer, 2003; Hayes, Follette, & Linehan, 2004), are 
proposed to have a theoretical relationship with insomnia (Lundh, 2000; Lundh, 2005).  
Lundh’s (2000; 2005) theories have an underpinning in Acceptance and Commitment 
Therapy theory, a mindfulness based theory.  Acceptance and Commitment Therapy 
theory provides a shift in how one views psychopathology and functioning, incorporating 
aspects of mindfulness into the formulation.  Based on this model (Lundh, 2000; Lundh 
2005), insomnia is incompatible with mindfulness (Baer, 2003; Hayes, Follette, & 
Linehan, 2004).  Lundh (2005) suggests that mindfulness enables cognitive deactivation 
thereby decreasing cognitive rumination and arousal which allow for better sleep quality 
(i.e. less likelihood of insomnia symptoms).  Moreover, the level of mindfulness would 
theoretically influence the impact that stress (precipitating factor) has on an individual.  If 
one were to have an accepting and nonjudgmental disposition, theoretically, one would 
have less of a psychological and physiological response to the stressor.    Given that 
cancer specific stress is likely to be at the fulcrum of precipitating insomnia within a 
cancer population, placing an individual who is predisposed into a state of acute insomnia 
(Savard & Morin, 2001; Spielman et al., 1987; Spielman & Glovinsky, 1991), the 
relationship between mindfulness, symptoms of insomnia, and cancer specific stress is of 
interest.   
Research in Mindfulness-Based Stress Reduction (MBSR) suggests that greater 
mindfulness is associated with decreased stress and better sleep quality, specifically 
among cancer populations to include breast cancer populations (Carlson & Garland, 
2005; Carlson, Speca, Patel, & Goodey, 2003).  Mindfulness-Based Stress Reduction 
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interventions have found that mindfulness based treatment decreases stress and improves 
sleep among cancer patients (For review, see Smith, 2005) suggesting further exploration 
into these relationships is theoretically appropriate.   
In the context of cancer, the hypothesis that mindfulness is related to insomnia has 
been indirectly evaluated.  Several studies among cancer patients, including individuals 
with breast cancer, found that sleep quality improved following completion of MBSR 
interventions (Carlson & Garland, 2005; Carlson et al., 2003).  Mindfulness-Based Stress 
Reduction, like ACT, focuses on facilitating the practice of mindfulness (for review, see 
Bear, 2003).  Moreover, MBSR is a structured treatment modality utilized to decrease 
stress, by means of psycho-education, mindfulness mediation, and hatha yoga (Kabat-
Zinn et al., 1992).  The treatment normally lasts 8 weeks and often includes one full day 
retreat (Kabat-Zinn et al., 1992).  Despite the primary goal being stress reduction, MBSR 
has been shown to be efficacious in the reduction of numerous symptoms for a variety of 
maladies among individuals with medical conditions such as fibromyalgia and cancer (for 
review, see Baer, 2003).   
Several studies suggest that MBSR improves sleep quality among individuals 
with cancer (Carlson & Garland, 2005; Carlson et al., 2003).  Interestingly, the 
mechanism of change suggested in Carlson and colleagues studies (2003; 2005) has not 
been empirically evaluated in reference to the relationship between mindfulness, stress 
related to cancer, and symptoms of insomnia.  Further investigations are required to 
identify whether mindfulness is a factor directly related to stress and symptoms of 
insomnia.  Increased engagement in mindfulness practice is associated with improved 
sleep and decreased level of stress (Carlson & Garland, 2005; Carlson et al., 2003; Ong, 
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Shapiro, & Manber, 2008) potentially via cognitive deactivation (Lundh, 2005).  
However, MBSR studies look at the practice of mindfulness meditation and not the trait 
of mindfulness that is proposed as a potential factor associated with insomnia by Lundh 
(2005).  In addition, other factors in MBSR treatments utilized in the aforementioned 
studies by Carlson and colleagues (2003, 2005), such as participation in a study or 
psycho-education, may be attributable to improvements in sleep quality (i.e. decrease in 
symptoms associated with insomnia).  Given that Carlson and colleagues (2003; 2005) 
did not conduct randomized controlled trials, additional factors such as regression to the 
mean, that is – the propensity for extreme scores to regress toward the mean of a 
distribution on second administration of any measure (Kazdin, 2003) cannot be ruled out.  
Moreover, one MBSR study that utilized a control group design did not find a difference 
in sleep quality between breast cancer patients in a MBSR intervention group relative to 
an attention placebo group (Shapiro, Bootzin, Figueredo, Lopez, & Schwartz, 2003), 
challenging the assumption that the trait of mindfulness is a primary factor strongly 
associated with sleep parameters.   
The purpose of this study is to expand upon previous findings by exploring the 
interrelationship between stress associated with cancer and symptoms of insomnia among 
an outpatient breast cancer population.  Additionally, this study aimed to extend upon 
previous research by conducting a novel and direct exploration into the relationship 
between cancer specific stress, symptoms of insomnia, and the trait of mindfulness, 
independent of the practice of mindfulness exercises.  Our first goal was to explore the 
severity of insomnia symptoms among an outpatient breast cancer population given that 
few studies have quantitatively done so (Aim I).  Next we aimed to investigate the unique 
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factors that predispose individuals with breast cancer to increased symptoms of insomnia 
(Aim II), the degree to which cancer specific stress precipitates insomnia symptoms (Aim 
III), and factors that perpetuate (dysfunctional beliefs and attitudes about sleep) 
symptoms of insomnia (Aim IV).  Lastly we aimed to evaluate the role of mindfulness in 
potentially moderating the relationships between cancer specific stress and insomnia 
symptoms (Aim V), and beliefs and attitudes about sleep and insomnia symptoms (Aim 
VI).   
A review of literature pertinent to the present study will be provided.  A brief 
background on cancer and QoL is presented to highlight the importance in understanding 
insomnia symptoms among individuals with breast cancer.  Next, research on cancer and 
sleep is delineated, with a focus on breast cancer research.  Thereafter, a brief overview 
of insomnia is provided, given the foundation for the present study is derived, in part, 
from insomnia research conducted within nonmedical populations.  Subsequently, an 
overview of insomnia in the context of breast cancer is discussed.  Then, background on 
mindfulness and ACT theories is presented, in addition to the application of ACT 
constructs (i.e. mindfulness) to symptoms of insomnia in the context of cancer.  
Following the study’s rationale, methods for the present study are provided.   Lastly, 
results of the study and a discussion of the findings are presented. 
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CHAPTER 2:  LITERATURE REVIEW 
Cancer 
Cancer is a term used to describe a group of diseases characterized by the 
uncontrollable growth of abnormal cells.  This group of diseases is a widespread health 
issue, affecting a large portion of the population.  The National Cancer Institute estimated 
that 10.1 million individuals in the United States were living with cancer or had a history 
of cancer (were in remission) in the year 2002.  Moreover, almost 1,400,000 new cases of 
cancer were estimated to be diagnosed in the year 2006, with the lifetime risk for 
developing cancer being one in every two men, and one in every three women (American 
Cancer Society, 2006).     Breast cancer is the most common non-skin cancer among 
women in the United States.  According to the Surveillance Epidemiology and End 
Results (SEER) report it is estimated that 182,460 women were diagnosed with breast 
cancer in the year 2008.  Moreover, the lifetime risk among women for developing breast 
cancer is estimated to be one in every eight (Ries et al., 2008).   
 As cancer treatments become more advanced and effective, survival rates 
improve.  From 1974-1976 the five year survival rate for all cancers was 50%, however, 
this rate improved to 65% between the years of 1995-2001 (American Cancer Society, 
2006).  The overall five year survival rate for 1996-2004 is estimated at 88.7% for 
individuals with breast cancer (Ries et al., 2008).  Despite improvements in treatment 
leading to better medical prognoses, cancer continues to be a significant stressor that 
impacts countless aspects of a person’s life.  Moreover, breast cancer appears to bring 
forth the greatest level of stress relative to other cancer diagnoses (for review, see 
Shapiro et al., 2001).  In a review of the literature, Shapiro and colleagues (2001) found 
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that numerous factors related to breast cancer lead to stress including the possibility of 
recurrence and threat to life.  In addition, factors unique to breast cancer include the 
numerous challenges to body images, sexuality, fertility, and one’s overall sense of 
femininity (e.g. breast surgery, hair loss, early menopause).  Given that breast cancer is a 
significant stressor (e.g. diagnosis, treatment, recurrence, employment) and psychosocial 
variables such as stress are associated with QoL (Kreitle et al., 2007; Shapiro et al., 
2001), it is not surprising that individuals with cancer are at risk for developing poorer 
QoL (Dunn et al., 2006). 
Cancer and Quality of Life 
 The physiological and psychological effects of breast cancer and associated 
treatments implemented are noteworthy, and linked with decreased QoL, which more 
specifically refers to a number of factors including an individual’s subjective general 
health, physical functioning, physical symptoms, emotional functioning, cognitive 
functioning, role functioning, social well-being and functioning, sexual functioning, and 
existential issues (Fayers & Machin, 2000).  Research has demonstrated a decrease in 
overall QoL among individuals with cancer (Dunn et al., 2006).  Moreover, individuals 
with cancer are more likely to report poorer QoL, relative to individuals without cancer 
(Thome, Dykes, & Hallberg, 2004).  Among individuals with cancer including breast 
cancer, elevated levels of perceived stress and distress (Kreitler et al., 2007; Shapiro et 
al., 2001) and symptoms of anxiety and depression (Frick et al., 2006; Shapiro et al, 
2001) are often associated with poorer QoL.   
Demographic variables are also strongly and differentially associated with QoL 
among individuals with cancer (Mystakidou et al., 2007).  In reference to gender, women 
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consistently report poorer QoL, relative to men (Parker et al., 2003; Thome et al., 2004).  
Studies have also suggested that being happily married (Shapiro et al., 2001), is 
associated with enhanced QoL (Parker et al., 2003).  Such findings support previous 
research suggesting that social support positively influences QoL among individuals with 
cancer (Houck, Avis, Gallant, Fuller, & Goodman, 1999).  In addition, having a higher 
education is associated with enhanced QoL among cancer patients (Parker et al., 2003).  
The relationship between education and QoL among breast cancer patients was supported 
by Janz and colleagues (2005), who found higher education to buffer an association 
between receiving chemotherapy and poorer QoL.  One may argue that individuals with 
lower education have difficulty understanding and communicating about complex 
medical information, thereby causing stress. The relationship between age and QoL is not 
well understood.  While some researchers have found a relationship between older age 
and poorer QoL (Parker et al., 2003; Thome et al., 2004), a study conducted among 
women with breast cancer, found that younger women reported poorer QoL on several 
subscales (emotional and social functioning, body image, and future prospective) relative 
to women who were over 70 years of age (Janz et al., 2005).  Therefore, the relationship 
between age and QoL may be unique among breast cancer patients relative to other 
cancer populations.  Perhaps lower QoL among younger individuals with breast cancer is 
because of concerns surrounding infertility, recurrence, sexuality, and physical changes.  
Surprisingly, some researchers have found that certain medically-related variables 
associated with one’s cancer, such as stage of cancer, are associated with QoL to a lesser 
degree relative to other variables such as demographic variables (Parker et al., 2003).  
Factors such as time lapse since diagnosis, recurrence status, treatments, and stage of 
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disease are not strongly associated with QoL (Janz et al., 2005; Parker et al., 2003).  
However, specific to breast cancer patients, one study found that women who received 
breast conserving surgery, opposed to mastectomy with reconstruction, reported higher 
QoL on the body image domain (Janz et al., 2005).  Perhaps, women who receive 
mastectomies with reconstruction as opposed to breast conserving surgery experience 
more drastic changes to their physical appearance prior to the reconstruction.      
Psychological Factors 
 Emotional functioning, such as depression and anxiety, is a component of QoL 
that is found to have a strong interrelationship among individuals with breast cancer 
(Shapiro et al., 2003).  Parker and colleagues (2003) found that among a heterogeneous 
sample of individuals with cancer, being older and having better social support correlated 
with lower levels of anxiety.  In reference to depression, cancer patients who were 
married, older, and had better social support were less likely to indicate depressive 
symptoms (Parker et al., 2003).   
 Understanding factors associated with QoL among breast cancer patients can aid 
in developing ways to enhance well-being.  Given that more individuals are living longer 
with breast cancer, and/or surviving cancer, researchers are developing ways to aid 
individuals in living longer while maintaining a suitable QoL.  Such research has lead to 
findings that sleep quality and QoL are related constructs (Fortner et al., 2002; for 
review, see Kvale & Shuster, 2006; Mystakidou et al., 2007; Schubert et al., 2002).  
Therefore, an understanding of sleep patterns and sleep dysfunction among individuals 
with breast cancer may aid in developing new ways to improve QoL among individuals 
with breast cancer in the future.  
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Cancer and Sleep Quality 
The relationship between sleep quality and QoL is important, given the high 
prevalence of poor sleep quality and insomnia among individuals with cancer, including 
breast cancer (Engstrom, Strohl, Rose, Lewandowski, & Stefanek, 1999; Frontner et al., 
2002; for review, see Kvale & Shuster, 2006; Mystakidou et al., 2007; Savard et al., 
2001). Indeed, sleep quality and QoL are interrelated among individuals with cancer, 
including breast cancer patients (Fortner et al., 2002; for review, see Kvale & Shuster, 
2006; Mystakidou et al., 2007; Schubert et al., 2002).  Among a sample of breast cancer 
patients, poor sleep quality correlated with several constructs including lower ability to 
function generally, more physical pain, less energy for daily tasks, and more 
psychological difficulties (Fortner et al., 2002).    
Insomnia 
Due to inconsistent methods utilized by researchers, epidemiological studies yield 
variable information in reference to the prevalence of insomnia (difficulty initiating sleep, 
maintaining sleep or nonrestorative sleep; DSM-IV-TR; American Psychiatric 
Association, 2000; Edinger et al., 2004) among individuals with cancer.  While some 
studies utilize specific research criteria to quantify insomnia, others do not use 
quantitative criteria (e.g. recommended cutoffs for sleep latency, standardized measures), 
and rely on unstandardized measures.  The variability in measurement and criteria has 
lead to a vague estimate of insomnia symptoms prevalence among individuals with 
cancer.   Despite the specific criteria being utilized, research suggests that an estimated 
19% to 63% of individuals with cancer report insomnia (for review, see Kvale & Shuster, 
2006).  The prevalence of insomnia symptoms among breast cancer patients ranges from 
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37% to 63% (Davidson et al., 2002; Fortner et al., 2002; Koopman et al., 2002).  
Insomnia appears to be particularly high among breast cancer patients. Davidson and 
colleagues (2002) found that prevalence of insomnia symptoms was highest among 
individuals with breast and lung cancer relative to individuals with other forms of cancer.  
Moreover, when individuals with breast cancer were compared to healthy controls, breast 
cancer patients were found to have significantly more sleep disturbances (Carlson, 
Campbell, Garland, & Grossman, 2007).  Estimates of 58% to 75% of cancer patients 
report symptoms of insomnia that are chronic (lasting greater than 6 months), with the 
duration of insomnia symptoms ranging on average from 19 months to 48 months 
(Davidson et al., 2002; Savard et al., 2001).  Such findings highlight the importance in 
addressing and understanding symptoms of insomnia among individuals with breast 
cancer.   
Defining Insomnia 
The term insomnia refers to a perception or complaint of insufficient sleep due to 
difficulty falling asleep, frequent awakenings throughout the night with difficulty 
returning to sleep, waking up too early in the morning, or unrefreshing sleep (National 
Heart, Lung, and Blood Institute, 1995).  The nighttime symptoms of insomnia coexist 
with daytime consequences such as sleepiness, fatigue, irritability, or diminished 
concentration (National Heart, Lung, and Blood Institute, 1995).   
Primary versus Secondary versus Comorbid Insomnias 
Insomnia can present as a symptom secondary to a medical condition (e.g. 
degenerative neurological conditions, endocrine conditions), present as a primary 
disorder (Harvey, 2001), or present as a comorbid disorder (Lichstein, 2006). 
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Categorization in large part depends on the conceptualization of the etiology of the 
insomnia, and the conceptualization of insomnia as a disorder versus a symptom.     
Primary insomnia is conceptualized as being the central problem for the 
individual, as opposed to the byproduct of a medical or psychological disorder (DSM-IV-
TR; American Psychiatric Association, 2000).  Additionally, it is conceptualized as 
occurring on an independent course from other disorders.  In order to meet DSM-IV-TR 
criteria for primary insomnia disorder, an individual must have a predominant complaint 
of insufficient sleep due to difficulty falling asleep, frequent awakenings throughout the 
night with difficulty returning to sleep, waking up too early in the morning, or 
unrefreshing sleep, lasting for at least one month (DSM-IV-TR; American Psychiatric 
Association, 2000; for a review, see Harvey, 2001).  The American Academy of Sleep 
Medicine (AASM) utilizes more explicit criteria for a diagnosis of primary insomnia by 
requiring the presence of at least one daytime symptom in association with the nighttime 
criteria also endorsed by DSM-IV-TR (Edinger et al., 2004).  Furthermore, Lichstein and 
colleagues (2003) composed quantitative criteria for insomnia that enables frequency and 
duration to be incorporated as criteria.  Quantitative criteria for insomnia includes a sleep 
onset latency or wake time after sleep onset of greater than or equal to 31 minutes, 
occurring at least three nights a week, for at least 6 months (Lichstein, Durrence, Taylor, 
Bush, & Riedel, 2003).  According to the International Classification of Sleep Disorder, 
Revised (ICSD-R) produced by the American Academy of Sleep Medicine, insomnia 
lasting less than one month is acute, insomnia lasting from one month to six months is 
subacute, and insomnia lasting longer than six months is chronic (ICSD-R; American 
Academy of Sleep Medicine, 2002).   
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Insomnia that is secondary to a medical disorder is conceptualized as a symptom 
of another condition, as opposed to a primary disorder (DSM-IV-TR; American 
Psychiatric Association, 2000; Harvey, 2001).  Therefore, insomnia is secondary when 
the etiology of insomnia is attributable to a physiological change from a medical 
condition (e.g. degenerative neurological disorders, endocrine conditions).  Although the 
onset or treatment of some conditions such as cancer may cause a secondary insomnia, 
when the insomnia is maintained and becomes chronic, additional factors are likely 
associated with the course of insomnia.  For example, medications for certain types of 
cancer treatment may precipitate an acute insomnia by increasing physiological arousal, 
but additional factors such as behaviors or cognitions in reaction to the insomnia (trying 
to catch up on sleep, take naps, accepting the changes in sleep) may be what maintains 
the cycle of insomnia following completion of the medication.  In such situations, 
Lichstein (2006) proposes that the insomnia is better conceptualized as comorbid 
insomnia, given that the cancer becomes one of many factors associated with the 
insomnia.  Comorbid insomnia refers to an insomnia that coexists with another condition 
(Lichstein, 2006).  In the context of comorbid insomnia, the insomnia and other condition 
fail to have an explicit physiological relationship or a continuing causal nature, but do 
coexist.  The relationship between the two conditions may change throughout the course, 
but they remain associated with one another (Lichstein, 2006).  Given that cancer is 
conceptualized as a stressor often associated with the onset of insomnia, and may or may 
not be the means of a physiological shift causing insomnia, insomnia in the context of 
cancer will be conceptualized as comorbid insomnia.  Therefore, in the presence of 
predisposing factors (e.g. gender, age) the physiological and psychological stress of 
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cancer can precipitate insomnia, while factors such as beliefs about sleep can perpetuate 
insomnia into a chronic course.  In light of the often chronic nature of insomnia among 
cancer populations (Davidson, 2002), this categorization is deemed appropriate.  In an 
article evaluating insomnia in the context of cancer, Savard and Morin (2001) 
recommended diagnostic criteria for insomnia disorder that includes ICSD and DSM-IV-
TR criteria.  This criteria is the same as that for primary insomnia, but has been deemed 
appropriate for applying to individuals with comorbid cancer and insomnia.  Please refer 
to Table 1 for a visual depiction of criteria for conceptualizing comorbid insomnia in the 
context of cancer. 
Three-factor Model 
 Insomnia is associated with numerous psychological and physiological 
precipitants (Espie, 2002; Harvey, 2002).  The three-factor model developed by Spielman 
and colleagues (1987; 1991) demonstrates the theoretical inner workings of psychological 
and physiological factors in conceptualizing the development and maintenance of 
insomnia (for a review, see Perlis et al., 2005; Spielman et al.,1987; Spielman & 
Glovinsky, 1991).  Within this model, predisposing, precipitating, and perpetuating 
factors contribute to the development and continuance of insomnia.  Predisposing factors 
are physiological or psychological factors that put an individual at an increased risk of 
experiencing insomnia, such as, gender, hyperarousal as a trait, or a disposition towards 
ruminative thought processes.  Precipitating factors are acute psychological or 
physiological stressors such as an illness (e.g. cancer; Savard & Morin, 2001), divorce, or 
travel.    Together, the precipitating and predisposing factors contribute to the onset of 
acute insomnia.  The perpetuating factors maintain insomnia, thereby contributing to the 
26 
 
 
development of insomnia from an acute form to a more chronic form.  Maladaptive 
thoughts and behaviors are thought to be at the core of perpetuating factors, such as 
staying in bed for too long without falling asleep or believing eight hours of sleep is 
always necessary to feel rested (Morin, Blais, & Savard, 2002; Perlis et al., 2005; 
Spielman et al., 1987; Spielman & Glovinsky, 1991). 
Three-factors in the Context of Breast Cancer 
 The three-factor model can be utilized to understand comorbid insomnia as it 
occurs in the presence of breast cancer.  In review of research, Savard and Morin (2001) 
delineated possible risk factors within the three-factor model in relation to cancer 
patients’ experience of insomnia.  These factors, in addition to other factors derived from 
additional literature focusing on breast cancer patients, are reviewed below.  A visual 
depiction of the present studies proposed three-factor model of insomnia in relation to 
breast cancer is provided in Figure 1. 
Predisposing Factors.  Fundamental factors that increase the likelihood of an 
individual developing insomnia among cancer populations and the general population 
include heightened cognitive and physiological arousal, gender, age, history of sleep 
difficulties, and the presence of a psychological disorder (Morin, 1993; for review, see 
Savard & Morin, 2001).   
An additional predisposing factor that is unique to cancer is the type of cancer 
diagnosis an individual has (Davidson et al., 2002).  Individuals with certain types of 
cancer are more likely to develop symptoms associated with insomnia.  Higher levels of 
insomnia have been demonstrated among individuals with breast and lung cancer, relative 
to other cancer diagnoses (Davidson et al., 2002).  In a survey study conducted by 
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Engstrom and colleagues (1999) 45% of outpatients with breast or lung cancer reported 
sleep difficulties occurring most nights of the week.  Davidson and colleagues (2002) 
also found breast and lung cancer patients to endorse insomnia at a higher rate relative to 
individuals with other forms of cancer.  However, among the individuals with breast or 
lung cancer, the type of diagnosis (breast or lung) did not predispose an individual to a 
greater degree (Engstrom et al., 1999).  One reason why breast cancer patients in 
particular may have a higher prevalence of insomnia is that individuals with breast cancer 
report the highest level of stress relative to other cancer diagnoses (for review, see 
Shapiro et al., 2001).  Perhaps the higher level of stress among individuals with breast 
cancer is attributable to unique issues associated with breast cancer treatment such as 
changes related to body image, sexuality, fertility, and one’s overall sense of femininity 
(e.g. breast surgery, hair loss, early menopause). 
Similar to findings among the general population (National Heart, Lung, and 
Blood Institute, 1995; Sateia, Doghramji, Hauri, & Morin, 2000), higher rates of 
insomnia are found among women relative to men (Hugel, Elleshaw, Cook, Skinner, & 
Irvine, 2004) among cancer populations.  Among women, post-menopausal and 
perimenopausal women are more likely to experience insomnia than pre-menopausal 
women (National Heart, Lung, and Blood Institute, 1995; National Sleep Foundation, 
1998).  This may in part be attributable to vasomotor symptoms, given night sweats have 
been associated with insomnia among breast cancer patients (Bardwell et al., 2008), and 
early menopause can be a consequence of treatment.  However, some studies have found 
that among breast cancer patients, physiological markers such as endocrine and 
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sympathetic nervous system function, fail to correlate with psychological indices 
including sleep (Carlson et al., 2007). 
Although increased age has been demonstrated as a predisposing factor among the 
general population (National Heart, Lung, and Blood Institute, 1995; Sateia et al., 2000), 
findings in reference to this association among individual with cancer, and more 
specifically breast cancer, is inconsistent.  Interestingly, age does not consistently predict 
QoL among cancer patients (Janz et al., 2005; Parker et al., 2003; Thome et al., 2004).  
Likewise, age does not consistently predict sleep quality among individuals with cancer 
(Davidson et al., 2002; Engstrom et al., 1999).  While some have found an inverse 
relationship between age and insomnia among individuals with cancer, with younger age 
increasing the likelihood of insomnia (Davidson et al., 2002), others have found older age 
as a predisposing factor in developing insomnia (Engstrom et al., 1999).  The only 
noteworthy difference observed between these two studies was that Davidson and 
colleagues (2002) utilized a significantly larger sample size relative to Engstrom and 
colleagues (1999).    However, most recently, Bardwell and colleagues (2008) did not 
find any relationship between insomnia and age among a sample of 2,645 women treated 
for breast cancer. 
Psychological disorders and their associated symptoms commonly correlate with 
insomnia among the general population, heterogeneous cancer populations, and breast 
cancer populations (Bardwell et al., 2008; Espie, 2002; Ford & Kamero, 1989; Hoehn-
Saric, 1981; Roth & Roehrs, 2003; Thase, 2005).  Moreover, the most common 
comorbidity found among non-medically ill populations with insomnia is a psychological 
disorder, with one half of patients with insomnia having a primary psychological disorder 
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(Roth & Roehrs, 2003; Thase, 2005).  Anxiety (Hoehn-Saric, 1981) and depression 
(Espie, 2002; Ford & Kamero, 1989; Perlis, Giles, Buysse, Tu, & Kupfer, 1997; Roth & 
Roehrs, 2003) are among the most notable psychological correlates of insomnia among 
the general population.  Davidson and colleagues (2002) found mood to correlate with 
insomnia among both heterogeneous cancer populations and the general population, with 
low or variable mood predisposing an individual to develop insomnia.  Moreover, 
depression has been demonstrated as a significant predictor of insomnia (Bardwell et al., 
2008) and sleep disturbances (Koopman et al., 2002; Palesh et al., 2007) among women 
treated for breast cancer.  Additionally, Carlson and colleagues (2007) found that breast 
cancer patients reported higher levels of depression, anxiety, and sleep difficulties, 
relative to healthy controls.  Therefore, it is likely that the relationship between 
psychological disorders and insomnia is similar among the general population and breast 
cancer populations.  In addition to mood disorders, a previous diagnosis of a sleep 
disorder is predictive of developing insomnia among individuals with cancer (Engstrom 
et al., 1999).  Savard and Morin (2001) concur, proposing that a history of insomnia is a 
potential predisposing factor associated with the inception of insomnia following a 
diagnosis of cancer.   
Savard and Morin (2001) proposed that the trait of hyperarousal is a probable 
predisposing factor of insomnia for individuals with cancer; however this has not been 
directly investigated.  Research among the general population consistently finds an 
association between cognitive hyperarousal (an overactive mind) and insomnia (Espie, 
2001).  An individual with heightened cognitive arousal may lie in bed ruminating about 
many engaging thoughts (will my cancer metastasize, will I be sleepy tomorrow, will I 
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ever get to bed, if I continue to have poor sleep will my cancer return).  Increased 
cognitive activity often coexists with physiological arousal, further fueling a reaction to a 
stressor (precipitating factor), thereby contributing to poorer sleep quality.  Given such 
findings, individuals who are more hyperaroused are more likely to develop insomnia.  
However, one study investigating sleep quality failed to find a difference in sympathetic 
nervous system function between individuals with breast cancer and healthy controls 
(Carlson et al., 2007).  Such findings challenge the significance of physiological factors 
in predisposing an individual to insomnia.  Additionally, independent of precipitating 
factors, hyperarousal alone is unlikely to bring about insomnia (for review, see Espie, 
2001).  
Precipitating Factors.  Stressful life events (e.g. medical illness, loss of a loved 
one, traumatic event) are often the precipitant of sleep difficulties, including insomnia, 
when in the presence of predisposing characteristics (Healey et al., 1981; Lavie, 2001).  
Moreover, individuals who experience heightened stress, such as the experience of breast 
cancer are more likely to develop insomnia, relative to the general population (National 
Heart, Lung, and Blood Institute, 1995; Sateia et al., 2000).  Therefore, cancer is 
potentially a unique and robust precipitating factor that contributes to the onset of 
insomnia (for review, see Savard & Morin, 2001).  It is unique in that it is associated with 
a multitude of stressors that serve as potential precipitating factors.  These factors can 
consist of numerous stressors associated with cancer, including, but not limited to, 
diagnosis, treatment factors (e.g. surgery, hospitalization, radiation treatment, bone 
marrow transplantation, chemotherapy, hormonal therapy), and physical symptoms such 
as pain and nausea (for review, see Savard & Morin, 2001; Savard et al., 2001).  
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However, stress specific to cancer as a global construct has not been directly evaluated as 
a potential precipitating factor associated with insomnia.  Therefore, more research is 
required to understand the degree to which these factors are related.   
The initial diagnosis of breast cancer is a significant stressor that may precipitate 
insomnia.  Both Davidson and colleagues (2002) and Savard and colleagues (2001) found 
that among individuals with cancer, including breast cancer, who reported insomnia, 
almost one half reported that the sleep difficulties materialized around the time of the 
cancer diagnosis.  Given that among heterogeneous samples of individuals with cancer, 
individuals who reported insomnia, often reported the onset of difficulties around the 
time of the cancer diagnosis, the impact of stress associated with cancer is likely a strong 
precipitating factor associated with the onset of insomnia (Davidson et al., 2002; Hugel et 
al., 2004).   
However, the degree to which physiological and psychological stress associated 
with cancer treatments precipitates insomnia is not well understood.  Both physiological 
effects and emotional implications of treatments can potentially influence an individual’s 
sleep (for review, see Savard & Morin, 2001).  Findings in reference to the relationship 
between sleep and treatment type are variable.  Although hospitalizations have been 
associated with sleep difficulties (Sheely, 1996), some studies suggest that the specific 
types of cancer treatments an individual receives (e.g. radiation, chemotherapy, surgery, 
combination) do not differentially precipitate sleep difficulties (Davidson et al., 2002; 
Engstrom et al., 1999; Fortner et al., 2002).  Other studies have found an association 
between side effects of treatments such as pain, stress, and menopausal symptoms, and 
the onset of symptoms of insomnia (Savard et al., 2001).  Osoba and colleagues (1997) 
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found that among a heterogeneous sample of cancer patients receiving chemotherapy, 
individuals who reported nausea and vomiting were more likely to report insomnia.  
Radiotherapy has been associated with sleep disturbances, with one study finding an 
association between receiving radiotherapy and poorer sleep among a sample of women 
with breast cancer (Omne-Ponten, Holmberg, Burns, Adami, & Bergstrom, 1992).  
However, Omne-Ponten and colleagues (1992) found no differences in sleep difficulties 
between women who received mastectomy versus breast-conservation surgery.  
Therefore, it may be the severity of side effects experienced, and or the manner in which 
an individual perceives and interprets a treatment, more than the treatment modality 
itself.  Medications commonly utilized for treatment have also been associated with sleep 
difficulties, including tomoxifen (Davidson et al., 2002), steroids, stimulant 
antidepressants, bronchodilators/theophylline and diuretics (Hugel et al., 2004). 
Like treatment modalities, physical discomfort, such as pain and nausea, 
inconsistently correlates with insomnia when investigated among individuals with cancer.  
While some studies found physical discomfort or pain to significantly contribute to the 
onset of insomnia (Davidson et al., 2002; Fortner et al., 2002; Hugel et al., 2004; Palesh 
et al., 2007), other studies have failed to identify an association between physical 
discomforts and sleep difficulties (Engstrom et al., 1999).  A robust correlation has been 
identified between nocturia (awakenings due to a need to urinate) and sleep difficulties 
among of women with breast cancer (Frontner et al., 2002). 
As a whole, it appears that the level of stress an individual experiences during 
breast cancer can precipitate difficulty sleeping (Palesh et al., 2007).  A longitudinal 
study conducted among breast cancer patients identified stress at baseline as a predictor 
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of insomnia symptoms, thereby supporting its role as a precipitant (Palesh et al., 2007).  
However, stress specifically associated with the experience of cancer opposed to general 
stress, and its role in precipitating symptoms of insomnia, has yet to be investigated.  A 
cancer specific measure evaluating psychosocial stress associated with cancer was 
developed by Herschbach and colleagues (2004), but has not been applied to research 
investigating symptoms of insomnia.  The measure does include one question about sleep 
(I often have trouble sleeping). 
Perpetuating Factors.  Perpetuating factors maintain insomnia, thereby 
contributing to a chronic course.  Maladaptive sleep habits (e.g. getting in bed when not 
sleepy; napping) and dysfunctional beliefs about sleep (e.g. I need 8 hours of sleep to feel 
rested) are perpetuating factors associated with maintaining insomnia.  Taken together, 
these factors increase one’s level of anxiety and arousal, fueling a cycle of insomnia that 
can become chronic.  However, behaviors that are seemingly maladaptive among the 
general population are often utilized among individuals with cancer to combat the 
discomfort of treatment.  For example, patients receiving chemotherapy reported 
changing their sleep-wake patterns (e.g. going to bed earlier, sleeping during the day) and 
changing rest routines (e.g. napping, modifying activities) to address fatigue (Richardson 
& Ream, 1997).  Such behaviors, although functional within their context, may contribute 
to the maintenance of insomnia.  Savard and Morin (2001) suggest that similar to the 
general population with chronic insomnia, individuals with cancer who experience 
chronic insomnia may be engaging in activities that are not compatible with sleep, such 
as watching television in bed, which contributes to the maintenance of dysfunction by 
weakening the connection between the bed and sleep (Morin, 1993).      
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Cognitions incompatible with sleep (e.g. unrealistic sleep expectations, 
misperceptions of sleep difficulties, faulty attributions about daytime dysfunction, 
misperceptions about causal factors) are also likely to maintain insomnia within cancer 
populations (Morin, 1993; Savard & Morin, 2001).  Moreover, dysfunctional cognitions 
in reference to sleep and cancer (e.g. poor sleep will cause my cancer to return) have been 
hypothesized as perpetuating factors unique to individuals with cancer (Savard & Morin, 
2001).  However, this hypothesis has not yet been tested empirically. 
Maladaptive behaviors and cognitions that are incompatible with sleep are 
theorized to heighten anxiety and arousal, thereby strengthening the cycle of insomnia 
and maintaining the dysfunction (Edinger et al., 1998; Espie, 2002; Harvey, 2002; Lundh, 
2000; Lundh, 2005; Morin, 1993). Heightened arousal and anxiety, which are 
predisposing factors, have been identified among individuals with cancer reporting 
insomnia.  Thirty-six percent of individuals who endorsed sleep difficulties while under 
care of hospice (73 out of the 74 had advanced malignancies) attributed difficulties to 
worried thoughts (Hugel et al., 2004).  In addition, ruminative thinking may maintain 
insomnia by heightening ones level of predisposition via increased arousal, with 
individuals reporting thoughts of death, diagnosis, and family matters circling through 
their mind (Hugel et al., 2004).  These perpetuating factors fuel predisposing factors, 
strengthening the cycle of insomnia. 
Beyond the Three-factor Model 
Recently, researchers have proposed that mindfulness may aid in understanding 
the cycle of insomnia (Lundh, 2000; 2005).  Lundh (2000; 2005) expanded upon the 
previously described model of insomnia, incorporating mindfulness.  Given that 
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mindfulness has been associated with stress (the precipitating factor associated with 
insomnia), theories of mindfulness and insomnia are theoretically linked.  In addition, 
interventions targeting mindfulness have aided in improving sleep quality among 
individuals with cancer (for review, see Smith, 2005), suggesting mindfulness is a factor 
outside of the three factor model associated with sleep quality and the cycle of insomnia 
symptoms among individuals with cancer.  The theories and principles that create a 
foundation for Acceptance and Commitment Therapy (ACT) aid in developing an 
understanding of how constructs such as mindfulness may be associated with symptoms 
of insomnia via stress, among individuals with cancer. 
ACT Applied to Insomnia among Individuals with Cancer 
Background on ACT 
Acceptance and Commitment Therapy (ACT) is a third-generation behavior 
therapy that evolved in part from traditional Cognitive Behavior Therapy.  A central goal 
of ACT is “psychological flexibility,” which refers to one’s ability to engage in behaviors 
that are more consistent with personally held values and goals rather than having one’s 
behavior constrained by the avoidance of unpleasant internal experiences (i.e., thoughts, 
feelings, sensations, memories, and urges).  ACT addresses the importance of enabling 
the acceptance of subjective experiences (e.g., thoughts and feelings) in order to achieve 
enhanced psychological functioning.  In addition, ACT highlights the unhelpful nature of 
experiential avoidance (Eifert & Forsyth, 2005; Hayes 2004; Hayes & Smith, 2005; 
Hayes, Luoma, Bond, Masuda, & Lillis, 2006).  
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Experiential Avoidance 
Experiential avoidance is when an individual is unwilling to engage in life 
experiences such as thoughts, sensations, and behavioral patterns, and attempts to 
decrease or diminish the occurrence of these events (Hayes, Strosahl, & Wilson, 1999).  
In the context of sleep, experiential avoidance may be observed in a patient who 
unsuccessfully attempts to avoid and/or control the unwanted experience of a sleepless 
night or thoughts associated with breast cancer.  Such attempts may lead to a paradoxical 
effect, with avoidant attempts (e.g. getting in bed earlier to get more sleep, trying hard to 
fall asleep, trying to stop thoughts) actually inhibiting the ability to achieve a restful 
night’s sleep.  The opposite of avoidance is mindfulness.  Moreover, one cannot be in a 
state of mindfulness while also engaging in experiential avoidance.  From an ACT 
perspective, an individual may be better served by “accepting” and being “mindful” of 
each moment even if the possibility exists that a sleepless night may occur, unpleasant 
thoughts about breast cancer may be present, and the stress associated with cancer will 
fluctuate.  Therefore, an individual who is mindful may be presented with the stressor of 
breast cancer, but not experience symptoms of insomnia.  For example, a person may get 
diagnosed with breast cancer and avoid going to the doctor to start treatment.  The 
avoidance would cause an increase in anxiety and likely increase the distress associated 
with the diagnosis.  On the other hand, and individual may get a diagnosis of breast 
cancer, not engage in experiential avoidance and accept the diagnosis, and move forward 
with treatment.  This individual may experience less overall distress, given they are being 
present and engaging in the present moment, not making attempts to avoid.   
 
37 
 
 
Mindfulness 
Mindfulness is when internal thoughts and external experiences are brought into 
the present moment and acknowledged as opposed to judged (Baer, 2003; Hayes, 
Follette, & Linehan, 2004). Acceptance as defined by Hayes and colleagues (1999), is 
“abandonment of dysfunctional change agendas and an active process of feeling feelings 
as feelings, thinking thoughts as thoughts, remembering memories as memories, and so 
on (p. 77).”  Therefore, mindfulness implies acceptance (Hayes et al., 1999).  For the 
purposes of this study the term mindfulness will be used to refer to all aspects of 
mindfulness, including acceptance.  In ACT, the patient is taught that experiential 
avoidance and attempts to control unwanted experiences (such as sleepless nights and 
unpleasant cognitions) are likely to be ineffective or even counterproductive, and that the 
experience should be accepted without defense.  By gaining mindfulness, an individual 
experiences a decrease in distress (Brown & Ryan, 2003). 
ACT Model Applied to Insomnia 
The theoretical foundation of ACT, most notably mindfulness, has a potential role 
in explaining insomnia and factors associated with insomnia.  Lundh (2000; 2005) 
proposed a model of insomnia which expands upon previously proposed cognitive 
models of insomnia, incorporating mindfulness.  At a basic level, Lundh (2000) suggests 
that the core of insomnia exists at an interface; processes that are not compatible with 
sleep (e.g. cognitive and physiological arousal) and the manner in which one identifies 
with sleep (e.g. attribution and beliefs).  Understood from the three-factor model 
(Spielman et al., 1987; Spielman & Glovinsky, 1991), Lundh (2000; 2005) is referring to 
predisposing, precipitating, and perpetuating factors.  For example, an individual may 
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attribute life dissatisfaction with poor sleep, believe they can “fix” their sleep by getting 
in bed earlier, and then ruminate about how they are in bed early, still not able to sleep, 
and will thereafter attribute the following day’s maladies to the prior night’s poor sleep.  
While engaging in attempts to actively problem solve in bed, arousal is heightened and 
sleep is disturbed.  The act of trying to control the internal experiences that may inhibit 
sleep are often counterproductive.  Sleep itself is beyond our control; therefore attempts 
to control thoughts and the sleep state make thoughts more powerful and may increase 
arousal and activation. 
Heightened mindfulness likely reduces cognitive and physiological arousal given 
that these constructs are unable to be experienced simultaneously.  Moreover, in an 
insomnia treatment clinical trial that included mindfulness meditation as a component, 
increased mindfulness meditation practice was associated with decreased arousal (Ong et 
al., 2008).  One cannot engage in a mindful, accepting and cognitively deactivated state 
of being while engaging in heightened cognitive and physiological arousal (Lundh, 
2000).  Given that mindfulness is incompatible with the experience of insomnia one can 
infer that a relationship exists between lower levels of mindfulness and symptoms of 
insomnia.  Moreover, mindfulness may be the process through which the impact of 
cancer related stress and beliefs about sleep, relate to symptoms of insomnia.   However, 
this has not been empirically evaluated.  This leads to the present study’s investigation 
into mindfulness as a factor associated with symptoms of insomnia. 
Evidence of Relationship between Insomnia and Mindfulness 
Although Lundh’s (2000; 2005) proposed model of insomnia has not undergone 
the scrutiny of empirical research, several studies have demonstrated a potential link 
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between mindfulness and sleep quality among individuals with cancer.  Moreover, 
several studies have found mindfulness-based interventions to decrease stress and 
improve sleep quality among cancer populations (for review, see Smith, 2005).   
To illustrate, Carlson and Garland (2005) found improvements in sleep quality 
(PSQI-G), stress (Symptoms of Stress Inventory), mood (POMS), and fatigue (POMS 
subscale) among a heterogeneous sample of individuals with cancer who participated in 
an 8-week Mindfulness-Based Stress Reduction (MBSR) intervention.  In another study 
evaluating a MBSR intervention, a sample of individuals with cancer (primarily breast 
cancer) demonstrated significant improvements in overall QoL and sleep quality (Carlson 
et al., 2003).  At the start of treatment 40% of their sample reported poor sleep quality, 
whereas only 20% reported poor sleep quality at the end of treatment (Carlson et al., 
2003).  However, as described earlier, the MBSR intervention evaluated by Shapiro and 
colleagues (2003) failed to mirror the above results, with no significant difference in 
improvements in sleep quality between the MBSR group and attention placebo group.  
Nonetheless, a relationship between MBSR practice and improved overall outcome was 
observed.  Several experimental factors, such as a small sample size, a 6-week 
intervention opposed to the traditional 8-week intervention, and significant between 
group differences at baseline, may have compromised results (Shapiro et al., 2003).  
Although findings do suggest MBSR is efficacious in improving many aspects of an 
individual’s life, including sleep quality (Carlson et al., 2003; Carlson and Garland 2005) 
little is known about the mechanism of change and the characteristics of patients (Smith, 
2005), or the associations with outcomes.  Moreover, given somewhat inconsistent 
findings, and the lack of research directly evaluating mindfulness in reference to sleep 
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quality, mindfulness may or may not be associated with symptoms of insomnia among 
individuals with breast cancer.  Other elements of MBSR, such as psycho-education, may 
be the mechanism by which sleep quality improves and insomnia symptoms dissipate.  
Although a qualitative investigation into an MBSR study among cancer patients found 
that mindfulness was reported as a coping tool, there was no quantitative analysis 
confirming the strength of the relationship (Mackenzie, M., Carlson, L., Munoz, M., & 
Speca, 2007).  Only additional research can aid in better understanding previous findings. 
Taken together, Lundh’s (2000; 2005) model of insomnia and the above 
mentioned MBSR studies, suggest that mindfulness may be associated with cancer 
specific stress and symptoms of insomnia.  While Lundh (2000; 2005) provides a 
theoretical rationale, the MBSR studies suggest that these relationships may exist in the 
context of cancer related stress.  However, the relationship between mindfulness and 
symptoms of insomnia has not been directly evaluated by these studies, and no study to 
date has evaluated the degree to which mindfulness is directly related to symptoms of 
insomnia among individuals with cancer.  The MBSR research does suggest that if the 
relationship between mindfulness and insomnia symptoms exists, it is likely due to its 
interrelationship between factors associated with increased arousal such as cancer 
specific stress (precipitating factor) and dysfunctional beliefs and attitudes about sleep 
(perpetuating factor), and insomnia symptoms. 
Rationale 
Past research highlights the need for future investigations into insomnia among 
individuals with cancer (Hugel et al., 2004; Kvale & Shuster, 2006; Savard & Morin, 
2001).  Given that the prevalence of insomnia symptoms appears to be exceptionally high 
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among breast cancer patients (Davidson et al., 2002; Fortner et al., 2002; Koopman et al., 
2002; Savard et al., 2001), this specific population summons further inquiry.   
Exploration into understanding symptoms of insomnia and factors (predisposing, 
precipitating, perpetuating) associated with symptoms of insomnia among breast cancer 
patients is important given several factors.  Past research has often been conducted by 
means of non-standardized surveys limiting the validity of findings (Davidson et al., 
2002; Engstrom et al., 1999; Hugel et al., 2004).  Therefore, research that utilizes sound 
methodology will aid in developing a stronger understanding of factors related to 
symptoms of insomnia and cancer specific stress.  In addition, given the high prevalence 
of insomnia among individuals with breast cancer (Davidson et al., 2002; Fortner et al., 
2002; Koopman et al., 2002; Savard et al., 2001), an understanding of unique factors 
associated with symptoms of insomnia among this population, such as the impact of 
cancer specific stress, is of utility to many individuals.  Lastly, although studies 
evaluating MBSR suggest a correlation between mindfulness and sleep, among 
individuals with cancer (Smith, 2005), and a theoretical association between insomnia 
and mindfulness (Lundh, 2000; Lundh, 2005), the relationship between an individual’s 
level of mindfulness and symptoms of insomnia among breast cancer patients has not 
been empirically investigated.  Therefore, it is important to identify whether mindfulness 
is associated with insomnia symptoms among individuals with breast cancer, given 
interventions targeting such constructs are being utilized.  It is hypothesized that 
mindfulness is a factor outside of the three factor model, potentially associated with 
insomnia symptoms indirectly through precipitating and perpetuating factors. 
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Proposed Study 
This study was designed to investigate several aims derived from the literature 
delineated above.   The first aim of this study was to identify the severity of insomnia 
symptoms among an outpatient breast cancer sample and the severity relative to samples 
composed of individuals with other forms of cancer.  The second aim of this study was to 
examine the degree to which predisposing factors account for the variance in insomnia 
symptoms.  The following predisposing factors were investigated: age, depression, 
anxiety, and history of sleep difficulties.  The third aim of this study was to investigate 
the degree to which cancer specific stress (proposed precipitating factor) accounts for 
insomnia symptoms above and beyond predisposing factors.  The fourth aim was to 
determine the degree to which dysfunctional beliefs and attitudes about sleep (proposed 
perpetuating factor) account for variance in insomnia symptoms above and beyond 
predisposing and precipitating factors.  The fifth aim of this study was exploratory, and 
aimed to determine the degree to which mindfulness moderated the relationship between 
insomnia and cancer specific stress.  The sixth aim of this study was also exploratory, and 
investigated the degree to which mindfulness moderated the relationship between 
insomnia symptoms and dysfunctional beliefs and attitudes about sleep.     
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CHAPTER 3:  METHODS 
Participants 
As part of a larger study involving a heterogeneous cancer patient sample of 120 
individuals, recruitment continued until successful enrollment of 56 breast cancer patient 
participants was achieved.  Individuals who were interested in participating in this study 
and met all inclusion criteria were invited to participate.  Individuals who chose to 
participate received a twenty dollar gift card as compensation for their time.  No 
individual was excluded from this study on the basis of their race or ethnic background.  
Description of Sample 
The sample was recruited from two sites.  Participants were recruited from The 
Cancer Institute of New Jersey at Cooper University Hospital in Voorhees and in 
Stratford, New Jersey.  The Cancer Institute of New Jersey at Cooper University Hospital 
is one of thirty nine National Cancer Institute designated Comprehensive Cancer Centers 
in the nation.  The satellite facilities in Voorhees and Stratford, New Jersey provide 
comprehensive outpatient care to individuals with cancer.  The patient populations at the 
Voorhees and Stratford facilities are composed of patients with many types of cancers, 
with a larger percentage of patients having breast cancer, relative to other cancers.  This 
is representative of the prevalence of cancer in the United States, with breast cancer being 
the second most common cancer (American Cancer Society, 2006).  Specifics in 
reference to sample characteristics are provided in the results section.  
Participant Recruitment 
Recruitment took place from December 2007 through June 2008.  A research 
assistant approached cancer outpatients who were awaiting medical appointments in the 
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oncology outpatient clinic waiting room or examination rooms, or receiving 
chemotherapy in the infusion room.   The majority of patients were recruited in the 
infusion room.  Potential participants were provided with a brief verbal description of the 
study, including the purpose of the study, procedures involved in participation, inclusion 
and exclusion criteria, and the monetary compensation for their time.   
Inclusion and Exclusion Criteria 
 Please refer to Table 2 for inclusion and exclusion criteria.  In order to participate 
in this study individuals had to be 18 years of age or older and were being treated for 
cancer at The Cancer Institute of New Jersey at Cooper University Hospital, in Voorhees 
or Stratford, New Jersey.  Individuals were excluded from the study if they did not have a 
current cancer diagnosis, or had been in remission for more than one year.   
Procedures 
Prior to commencing the study, IRB approval was obtained from The Cancer 
Institute of New Jersey at Cooper University Hospital and Drexel University.  This study 
was completed anonymously.  Participants’ names and information were collected for the 
purposes of avoiding duplicate participation and verifying medical information.   
Protected participant information was kept separate from questionnaires.  Participants 
were instructed not to write their names or any other identifying information on the 
questionnaires. 
 Participants’ information were given an identification number as to keep their 
identities private, and all forms were stored in a locked filing cabinet in Suite A at The 
Cancer Institute of New Jersey at Cooper.  Information was only accessed by the 
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designated co-investigators, research assistants and the principal investigators.  The data 
analysis files did not contain any identifying information.   
Informed consent was reviewed orally and in writing to individuals who indicated 
they were interested in participating in the study and met inclusion criteria.  This 
occurred directly following the recruitment process.  Upon completion of informed 
consent, prior to the completion of measures, prospective participants who still chose to 
participate in the study, were asked to fill out a series of self-report measures.  In order to 
protect all participants, the telephone number of Behavioral Medicine Service at The 
Cancer Institute of New Jersey at Cooper University Hospital, in Voorhees, NJ, was 
provided to individuals who conveyed distress.  Following completion of the 
questionnaires, participants were provided with the twenty dollar gift card.   
Measures 
 Details regarding each scale included in the study can be found in Table 3.  
Psychometric properties, purpose, scoring/scaling, and number of items are included.   
Descriptive Information Form 
All participants completed the Descriptive Information Form (Appendix A), to 
report demographic information, medication use, use of hormonal therapies, and medical 
history.  This form was utilized to obtain information in reference to predisposing factors 
and potential covariates. 
Acceptance and Action Questionnaire-2   
The Acceptance and Action Questionnaire-2 (AAQ-2; Appendix B) is a 10-item 
self-report measure developed to assess experiential avoidance (Bond et al., submitted).  
The scale has two subscales.  The acceptance subscale investigates one’s ability to 
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experience, without attempting to change the experience (Hayes et al., 1999).  The 
psychological flexibility subscale investigates the ability to live within one’s values 
without engaging in behaviors that are aimed at avoiding unpleasant experiences (Hayes 
et al., 1999).  These two subscales can be combined to obtain an overall score for 
acceptance.  A total score was used for primary analyses in the present study and the 
subscales were used for post-hoc analyses.  The AAQ-2 is the second edition to the 
original AAQ, developed by Hayes, Strosahl, Wilson, Bissett et al. (2004).  The original 
AAQ has adequate internal consistency (Cronbach’s alpha = .70; the AAQ-2 does not 
have published validity and reliability information to date).  
Dysfunctional Beliefs and Attitudes about Sleep-Short Form 
The Dysfunctional Beliefs and Attitudes about Sleep-Short Form (DBAS-SF; 
Appendix C) is a 10-item self-report instrument used to assess the degree to which one 
subscribes to maladaptive thoughts, attitudes, attributions, and beliefs about sleep 
(Edinger, Wohlgemuth, Radtke, Marsh, & Quillian, 2001; Morin, 1993). The DBAS has 
a Cronbach’s alpha score of .81 and reliability ranging from .58 to .79 (Morin, 1993). 
Five Facet Mindfulness Questionnaire  
 The Five Facet Mindfulness Questionnaire (FFMQ; Appendix D) is a 39-item 
self-report measure that evaluates five components of mindfulness including 
nonreactivity to inner experience (e.g. allowing thoughts and feelings to exist without 
becoming submerged in them), observing (e.g. having an awareness of internal and 
external stimuli), describing (e.g. the labeling of individual experiences with language), 
acting with awareness (e.g. being in the present moment), and nonjudgmental of inner 
experience (e.g. not evaluating thoughts and feelings; Bear, Smith, Hopkins, 
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Krietemeyer, & Toney, 2006; Bear et al., 2008).  All five scales demonstrate adequate to 
good internal consistency with Cronbach’s alpha ranging from .79 - .91.  All five scales 
can be aggregated to create a single measure of mindfulness, which is what the present 
study utilized for primary analyses.  The separate subscales were used for post-hoc 
analyses. 
Hospital Anxiety and Depression Scale   
The Hospital Anxiety and Depression Scale (HADS;Appendix E) is a 14-item 
questionnaire used to assess the severity of anxiety and depression symptoms (Zigmond 
& Snaith, 1983).  The HADS is made up of two subscales, that being depression (D) and 
anxiety (A).  Scores between 8-10 suggest mild, 11-15 suggests moderate, and 16 or 
above suggests severe symptoms of anxiety or depression (Zigmond & Snaith, 1983).  In 
a review of studies, Cronbach’s alpha for the HADS-A ranged from .68 to .93 and .67 to 
.90 for the HADS-D (Bjelland, Dahl, Haug, & Neckelmann, 2002).  Therefore both 
subscales have adequate internal consistency.  
Insomnia Severity Index  
 The Insomnia Severity Index (ISI; Appendix F) is a 7-item questionnaire used to 
evaluate the severity of insomnia while focusing on daytime symptoms (Bastien, 
Vallieres, & Morin, 2001).  The ISI is a reliable (Cronbach’s alpha = .74) and valid (p < 
.05, comparing to self-reports of sleep) measure that is commonly used among sleep 
researchers (Bastien et al., 2001; Savard, Savard, Simard, & Ivers, 2005).  A clinical cut 
off score of 8 has been suggested to indicate a clinical level of insomnia symptoms 
(Savard et al., 2005). 
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Questionnaire on Stress in Cancer Patients – Revised 
The Questionnaire on Stress in Cancer Patients (QSCP-R; Appendix G) is a 23-
item self-report measure used to assess cancer specific stress (Herschbach et al., 2004).  
Questions focus on stressors specific to cancer, such as changes in body image, fear of 
disease prognosis and concerns about pain.  The QSCP-R is a valid and reliable measure, 
demonstrating a Cronbach’s alpha score of .89 (Herschbach et al., 2004; Herschbach et 
al., 2003). 
Data Analyses 
 Descriptive characteristics, frequency distributions, and normative data were 
collected, scored, entered and calculated to assess the distribution of variables.  
Characteristics, such as type of cancer treatment, were evaluated as potential covariates 
and included in primary analyses when deemed appropriate.  After preliminary analyses 
were completed, the following statistical analyses were conducted to investigate 
hypotheses.  
Aim I 
The first aim of this study was to identify the severity of symptoms of insomnia 
among an outpatient breast cancer sample.   Symptoms of insomnia were measured via 
the Insomnia Severity Index (ISI; Bastien et al 2001; Morin, 1993).  Scores on the ISI 
were also compared to scores for other cancer patients.  To evaluate Hypothesis 1a, 
descriptive analyses were conducted and evaluated to identify if the mean score on the 
ISI was equal to or great than 8, thereby suggesting a clinically significant level of 
insomnia symptoms.   Percentages of scores were also evaluated.  To evaluate hypothesis 
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1b, an ANOVA was run to identify if there was a significant difference between ISI 
scores between different types of cancer patients compared to breast cancer patients. 
Aim II  
The second aim of this study was to examine the degree to which predisposing 
factors (age, depression, anxiety, and history of sleep difficulties) accounted for variance 
in insomnia symptoms among an outpatient breast cancer patient population.  To evaluate 
the second aim of this study which consisted of hypothesis 2a, 2b, 2c, and 2d, a 
simultaneous entry linear regression was conducted with symptoms of insomnia (scores 
on the ISI) as the dependent variable, and predisposing factors (2a. age, 2b. anxiety, 2c. 
depression, 2d. history of sleep problems) as predictor variables.  Simultaneous entry was 
utilized to identify the degree to which each predisposing factor contributed to the 
variance in symptoms of insomnia. 
Aim III  
The third aim, that being to determine the degree to which cancer related stress 
accounts for variance in insomnia symptoms above and beyond predisposing factors as 
defined in Aim II, was evaluated via a hierarchical regression.  Covariates were entered 
into the first step; predisposing factors found to be significant in Aim II were entered into 
the second step.  Cancer related stress (as measured by the QSCP-R) was entered into the 
third step.  Symptoms of insomnia (scores on the ISI) was the dependent variable.  A 
hierarchical regression design aided in identifying the degree to which cancer specific  
stress accounts for variance of insomnia symptoms above and beyond predisposing 
factors.   
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Aim IV 
The fourth aim of this study was to determine the degree to which dysfunctional 
beliefs and attitudes about sleep accounted for variance in insomnia symptoms above and 
beyond precipitating and predisposing factors as determined by Aim II and Aim III.  A 
hierarchical regression was conducted to investigate the hypothesis.  Covariates were 
entered into the first step, predisposing factors into the second step, precipitating factors 
into the third step, and perpetuating factors into the fourth step.  Insomnia symptom 
severity was the dependent variable.   
Aim V (exploratory) 
The fifth aim of this study, that being to determine the degree to which acceptance 
(5a) and mindfulness (5b) moderate the relationship between cancer specific stress and 
insomnia symptoms, was evaluated via two separate regressions.   Covariates were 
entered into the regression first.  Centered independent variables (cancer specific stress 
and mindfulness) and the interaction term were entered second.   
Aim VI (exploratory) 
The sixth aim of this study, which was exploratory, was to determine the degree 
to which acceptance (6a) and mindfulness (6b) moderated the relationship between 
dysfunctional beliefs and attitudes about sleep and symptoms of insomnia.  Two separate 
regressions were conducted to independently evaluate measures of acceptance and 
mindfulness.  Centered independent variables (dysfunctional beliefs and attitudes about 
sleep and mindfulness or acceptance) and the interaction term were simultaneously 
entered second.  
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CHAPTER 4:  RESULTS 
Individuals who met inclusion criteria and were interested in participating in the 
study were included in the proposed analyses.  Eighty five percent of the individuals 
approached for the larger heterogeneous cancer study, which included 120 individuals, 
agreed to participate.  The participation rate for individuals with breast cancer only is not 
available.  Individuals who choose not to participate in the larger study indicated the 
following reasons for not engaging in the study: did not have enough time to complete 
the questionnaires, were not interested or felt too sick to complete the forms.  Prior to 
conducting the primary analyses, sample characteristics were defined, and variables 
under investigation were evaluated for reliability.  Additionally, sample data was 
compared to published means derived from cancer populations when such information 
was available.  Analyses of internal reliability on primary measures were conducted using 
Cronbach’s alpha.  Preliminary analyses were conducted to determine possible covariates 
for the primary hypotheses.  Primary hypotheses were investigated via several modes of 
analysis.  When significant findings emerged, post-hoc analyses were conducted. 
Sample Characteristics 
 Demographic information is presented in Table 4.  Fifty six breast cancer patients 
participated in the study, ranging from age 26 to 75 (age 26-40 [n=10]; age 41-60 [n=34]; 
age 61-75 [n=12]) with a mean of 50.61 years (SD = 11.28).  All participants were 
female.  Seventy three percent of participants reported they were Caucasian (n = 41), 
18% were African American (n = 10), 5% were Native American (n = 3), 2% were 
Hispanic (n = 1), and 2% were other (n = 2). 
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 Sleep characteristics including, diagnosed sleep disorder, and time at which any 
reported sleep disorder began, were collected.  In addition, history of sleep difficulty, the 
time at which the sleep difficulty began, and what the nature of the difficulty was, was 
collected and will be discussed at length in Aim II and the post-hoc analyses.  Only three 
individuals in the sample reported a diagnosed sleep disorder.   One individual reported a 
diagnosis of Restless Leg Syndrome diagnosed in March of 2004, one reported sleep 
apnea diagnosed in January of 2005, and one reported that they had surgery to correct an 
unspecified sleep disorder that began in January of 1995. 
Means and Normative Analyses 
 The means and standard deviations of sample scores and normative scores 
derived from publications for primary measures are reported in Table 5.  The sample 
means obtained from our study were compared with published mean values for each 
measure.   
 Both measures associated with sleep (DBAS-SF and ISI) were compared to 
published means.  When investigating insomnia symptom severity via the ISI (Bastien et 
al., 2001), our sample did not significantly differ from a sample of female breast cancer 
patients utilized to validate the ISI among cancer patients (Savard et al., 2005).  Our 
sample did have significantly fewer symptoms of insomnia relative to a clinical sample of 
individuals with sleep disorders (Bastien et al., 2001).  Individuals with breast cancer 
who participated in the study did report a clinically significant level of insomnia 
symptoms on the ISI (demonstrated by a score above 8; Savard et al., 2005) as indicated 
by a mean of 9.04 (SD=6.56).  On the DBAS-SF (Edinger et al., 2001; Morin, 1993), our 
sample reported significantly more dysfunctional beliefs and attitudes about sleep relative 
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to both a sample of individuals with insomnia and a nonclinical comparison group 
reported by Rumble et al., 2005.  To our knowledge, the DBAS-SF has not been utilized 
among cancer populations.  Therefore, no comparisons could be made between our 
sample and previously investigated cancer samples on DBAS scores. 
 In reference to cancer related stress as measured by the QSCP-R (Herschbach et 
al., 2004), our sample reported significantly more stress relative to the sample of female 
cancer patients investigated by Herschbach and colleagues (2004).  Moreover, our sample 
reported a clinically significant level of stress (M=1.85; SD=.65), as indicated by the 
mean score being above the suggested cut-off score of 1.5 (Herschbach et al., 2004).  In 
addition, the sample utilized by Herschbach and colleagues (2004) was in Germany and 
the measure has not been investigated in the United States.  Therefore, differences may 
be attributable to cultural factors.   
 Scores derived from our sample using the HADS (Snaith & Zigmond, 1994) 
Anxiety and Depression Subscales were not significantly different from scores derived 
from a non-clinical sample investigated by Crawford, Henery, Crombie, and Taylor 
(2001).  Moreover, our sample did not report clinically significant levels of depression 
not anxiety.   
 Both measures of mindfulness (FFMQ and AAQ-2) were compared to published 
norms.  The means obtained from Baer and colleagues (2008) validation study of the five 
mindfulness facets were utilized to obtain a total mindfulness score.  Analyses indicated 
that our sample endorsed significantly more mindfulness relative to the community 
sample investigated by Baer and colleagues (2008).  However, there was no significant 
difference between the level of mindfulness of our sample and the sample termed as the 
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“educated” group in Baer and colleagues (2008) study.  The educated group had an 
average of 18.2(SD=2.1) years of education (Baer et al., 2008).  Almost half of our 
sample had college degrees or higher, therefore our sample’s average level of education 
fell between the “educated” group and community sample (Baer et al., 2008).  In 
addition, our sample reported higher levels of acceptance on the AAQ-2 relative to a 
student and community sample collected by Bond and Colleagues (Submitted).   
Reliability Check 
 Internal consistencies for primary measures are presented in Table 6.  Primary 
measures utilized in the present study were evaluated for internal consistency reliability 
using Cronbach’s alpha (Cronbach, 1951).  All measures demonstrated reliability ranging 
from adequate to good (.79-.91), allowing for the confident interpretation of all scales.   
Preliminary Analyses 
Preliminary analyses for the present study included the evaluation of dependent 
measures, independent measures, and demographic variables for normality, distribution, 
and descriptive statistics.  A correlation matrix of all primary independent and dependent 
variables can be found in Table 7.  Cancer specific factors such as receiving 
chemotherapy were also evaluated as potential covariates.  Pearson correlations were 
used to evaluate continuous variables and ANOVAs to evaluate categorical variables.  
Demographic characteristics or cancer specific factors that did have a significant 
relationship with independent or dependent variables were controlled for by including 
them as covariates in the first step of regression analyses and independent variables 
entered into subsequent steps.   
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All primary measures were found to be normally distributed, aside from the 
Depression Subscale of the HADS.  The Depression Subscale distribution of participants 
was positively skewed (e.g. less depressed).  The log (y = log10(x +1)) was taken and 
analyzed in an attempt to normalize the distributions per recommendations of Fox (1991).  
This did normalize the distribution for the factor.  Therefore, both transformed and 
original scores for the HADS Depression Subscale were utilized and reported. 
The QSCP-R includes a question about sleep, “I often have trouble sleeping.”  To 
confirm that results in reference to insomnia were not attributable to this single question, 
analyses were run without the sleep question included.  No noteworthy differences were 
observed in results.  Therefore, reported results are using the standardized QSCP-R 
measure including all questions. 
Analyses of Covariates 
No relationships were identified between participant age, ethnicity, employment, 
education, stage of cancer, HRT treatment, metastatic status, or income with primary 
measures (ps > .05), and were therefore not included as covariates in analyses.  Marital 
status was significantly related to dysfunctional beliefs about sleep (as measured by the 
DBAS) as demonstrated via ANOVA analysis, F(5,50) = 3.64, p = .007, with divorced 
individuals reporting the highest level of dysfunctional thoughts about sleep, M=74.27, 
SD=10.27, and widowed individuals reporting the lowest level of dysfunctional thoughts 
about sleep, M=39.54, SD=21.14.  Medical and cancer specific factors, stage of cancer, 
having additional medical problems, being on hormone replacement therapy, having 
metastatic disease, and receiving a recommendation for hospice were not correlated with 
primary measures.  ANOVA analyses indicated that individuals who had surgery as an 
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intervention for their cancer reported significantly more symptoms of insomnia (as 
measured by the ISI; F(1,54)=4.63, p=.036) and greater cancer specific stress (as 
measured by the QSCP-R; F(1,49)=6.23, p=.016), relative to individuals who did not 
answer the question or individuals who did not have surgery.   In sum, marital status and 
having surgical intervention(s) were included as covariates in appropriate analyses.   
Statistical Power 
In order to identify power obtained for statistical analyses G Power (Faul, 
Erdfelder, Lang, & Buchner, 2007) was used.  The post-hoc power analysis was based on 
Aim III, which investigated the precipitating factor of cancer specific stress.   For Aim 
III, using an alpha level of .05, a medium effect size, and 56 participants, a power of .81 
was obtained for the regression analysis looking at an R2 increase conducted with two 
predictor variables entered on separate steps.    
Analyses of Hypotheses 
Aim I 
The first aim of this study was to identify the severity of symptoms of insomnia 
among an outpatient breast cancer sample.   Symptoms of insomnia were measured via 
the Insomnia Severity Index (ISI; Bastien et al., 2001; Morin, 1993).  A score equal to or 
above 8 (Savard et al., 2005) on the Insomnia Severity Index (ISI; Bastien et al., 2001; 
Morin, 1993) is indicative of clinically significant insomnia symptoms. 
Hypothesis 1a   
Breast cancer patients, on average, reported a clinically significant level of 
insomnia symptoms as indicated by a mean of 9.04 (SD=6.56) on the ISI.  Forty eight 
percent of participants in the sample indicated a clinically significant level of insomnia 
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symptoms, having an ISI score that was equal to or great than 8.  Please see Figure 2 for 
the complete distribution of scores on the ISI.  
Hypothesis 1b 
Breast cancer patients were compared with individuals with other forms of cancer 
who participated in the larger study the present study was housed under.  Other forms of 
cancer included lung (n=12), gynecological (n=22), colon (n=12), lymphoma (n=5), and 
prostate (n=3).  Only one participant had liver cancer, therefore this was not included as a 
comparison group.  Due to the small sample size for other forms of cancer presented 
findings should be interpreted with caution.   
Breast cancer patients did not report a significantly higher level of insomnia 
symptoms relative to individuals with lung cancer, gynecological cancer, colon cancer, or 
prostate cancer (ps>.05).  Breast cancer patients did endorse less symptoms of insomnia 
relative to individuals with lymphoma, t(55)=-4.06, p<.001, however, this was based on a 
sample size of 5.  There was no significant difference between individuals with breast 
cancer and lung cancer, [t(55)=-.05]; gynecological cancer, [t(55)=-.02]; colon cancer, 
[t(55)=1.64]; and prostate cancer, [t(55)=.08, p=.94], all ps>.10.  Means and standard 
deviations for other forms of cancer used as comparison groups can be found in Table 8. 
Aim II 
The second aim of this study was to examine the degree to which predisposing 
factors (age, depression, anxiety, and history of sleep difficulties) accounted for variance 
in insomnia symptoms among an outpatient breast cancer patient population.  Results 
obtained using the original HADS depression scores opposed to the transformed HADS 
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depression scores are reported.1  Having surgery, which was indicated on the 
demographics form, was entered into the analyses as a covariate given that symptoms of 
insomnia were found to correlate with having surgery.  All variables, including the 
covariates, were entered simultaneously into the linear regression.  Predisposing factors 
significantly accounted for variance in insomnia symptoms when controlling for the 
covariate of surgery (R=.65, p<.001).  See Table 9 for results from regression. 
Hypothesis 2a   
Age did not account for a significant amount of variance in symptoms of 
insomnia (p>.05) when controlling for the covariate surgery and additional independent 
variables (symptoms of anxiety, symptoms of depression, and a history of sleep 
difficulties).  Findings did not change (p>.05) when age was investigated as a categorical 
factor (age 26-40 [n=10]; age 41-60 [n=34]; age 61-75 [n=12]). 
Hypothesis 2b  
Symptoms of anxiety did not account for a significant amount of variance in 
symptoms of insomnia (p>.05) when controlling for the covariate surgery and additional 
independent variables (age, symptoms of depression, and a history of sleep difficulties).  
Hypothesis 2c 
Symptoms of depression did not account for a significant amount of variance in 
symptoms of insomnia (p>.05) when controlling for the covariate surgery and additional 
independent variables (symptoms of anxiety, age, and a history of sleep difficulties).  
 
 
                                                 
1 Results did not differ between the transformed and non-transformed data 
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 Hypothesis 2d 
A history of sleep difficulties significantly accounted for variance in symptoms of 
insomnia, (p<.001) when controlling for the covariate surgery and additional independent 
variables (symptoms of anxiety, symptoms of depression, and age).  While covarying for 
surgery, symptoms of insomnia significantly correlated with a history of sleep difficulties 
when simultaneously entered into the linear regression with symptoms of anxiety, 
symptoms of depression, and age, R²=.42, F(5,47)=6.75, p<.001.  
Aim III 
The third aim of this study was to determine the degree to which cancer related 
stress accounts for variance in insomnia symptoms above and beyond predisposing 
factors.  A history of sleep difficulties was the only proposed predisposing factor entered 
into the hierarchical regression for Aim III.  Other independent variables investigated in 
Aim II were not found to significantly contribute to the variance in symptoms of 
insomnia, and therefore, were not included.  Surgery was entered into the hierarchical 
regression on the first step as a covariate, history of sleep difficulties was entered in the 
second step as an independent variable, and cancer specific stress was entered on the 
third step as an independent variable.  See Table 10 for results from hierarchical 
regression. 
Hypothesis 3   
Cancer specific stress predicted insomnia symptoms above and beyond having 
surgical treatment(s) and a history of sleep difficulties, p<.001.  History of sleep 
difficulties remained significant in the model, p=.003.  Cancer specific stress and history 
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of sleep difficulties explained a significant proportion of variance in insomnia symptoms, 
R=.74, F(1,48)=18.07, p<.001.     
Aim IV 
The fourth aim of this study was to determine the degree to which dysfunctional 
beliefs and attitudes about sleep accounts for variance in insomnia symptoms above and 
beyond precipitating and predisposing factors.  A hierarchical regression was conducted 
to investigate this hypothesis.  Surgery and marital status were entered as covariates in 
the first step given findings that surgery correlated with cancer specific stress and 
insomnia symptoms, and marital status correlated with dysfunctional beliefs and attitudes 
about sleep.  History of sleep difficulties was entered on the second step as a predisposing 
factor.   Cancer specific stress was entered on the third step as a precipitating factor.   
Dysfunctional beliefs and attitudes about sleep was entered on the fourth step as a 
perpetuating factor.  Dysfunctional beliefs and attitudes about sleep were measured by 
the DBAS-SF (Morin, 1993).  Factors significantly contributing to the variance in 
insomnia symptoms (R=.74, p<.001). See Table 11 for results from hierarchical 
regression. 
Hypothesis 4 
Dysfunctional behaviors and attitudes about sleep did not significantly contribute 
to the variability in insomnia symptoms above and beyond covariates, predisposing 
factors, and precipitating factors identified in Aim II and Aim III (R2 Change=.001; 
p>.05).   
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Aim V (exploratory) 
 
The fifth aim of this study, which was exploratory, was to determine the degree to 
which acceptance (5a) and mindfulness (5b) moderate the relationship between cancer 
specific stress and symptoms of insomnia.  Surgery was included as a covariate in both 
regression analyses.  Acceptance was measured by the AAQ-2 (Bond et al., submitted), 
and mindfulness was measured by the FFMQ (Baer et al., 2006).  Two separate 
regressions were conducted to independently evaluate measures of acceptance and 
mindfulness.  The regressions were run as a simultaneous entry, with the covariate 
surgery, centered independent variables (cancer specific stress and mindfulness or 
acceptance) and the interaction term entered together.  See Tables 12 and 13 for results 
from the following regressions. 
Hypothesis 5a 
 Acceptance did not moderate the relationship between cancer specific stress and 
symptoms of insomnia (p>.05).   
Hypothesis 5b 
Mindfulness did not moderate the relationship between cancer specific stress and 
symptoms of insomnia (p>.05).   
Aim VI (exploratory) 
The sixth aim of this study, which is exploratory, was to determine the degree to 
which acceptance (6a) and mindfulness (6b) moderate the relationship between 
dysfunctional beliefs and attitudes about sleep and symptoms of insomnia.  Surgery and 
marital status were included as a covariate in both regression analyses.  Two separate 
regressions were conducted to independently evaluate measures of acceptance and 
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mindfulness.  Covariates, centered independent variables (dysfunctional beliefs and 
attitudes about sleep and mindfulness or acceptance) and the interaction term were 
simultaneously entered in a linear regression.  Results from analyses are presented in 
Tables 14 and 15. 
Hypothesis 6a 
Acceptance did not moderate the relationship between dysfunctional behaviors 
and attitudes about sleep insomnia symptoms (p>.05).  
Hypothesis 6b 
 Mindfulness did not moderate the relationship between dysfunctional behaviors 
and attitudes about sleep and insomnia symptom severity (p>.05). 
Post-hoc Exploratory Analyses 
 Several analyses were conducted to further explore significant findings from the 
primary analyses.  The present study investigated the nature of sleep difficulties indicated 
by participants.  The potential differences in cancer specific stress between breast cancer 
patients and individuals with other forms of cancer were investigated.  Questions on the 
QSCP-R were investigated to better understand the interrelationship between cancer 
specific stress and symptoms of insomnia.  Aspects of mindfulness were explored.  The 
subscales of the FFMQ were investigated to identify which of the five factors of 
mindfulness were associated with symptoms of insomnia.  In addition, the two factors of 
the AAQ-2 were investigated.  Dysfunctional beliefs and perceptions about sleep were 
also explored in more depth. 
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Nature of Sleep Difficulties 
 As reported in Aims I and II, sleep difficulties were pervasive among individuals 
with breast cancer.  These difficulties were further explored in reference to duration and 
presentation to better understand the experience of breast cancer patients.  Savard and 
colleagues (2001) found that 95% of individuals with breast cancer in their sample who 
reported insomnia had a chronic form of insomnia lasting greater than six months.  
Although the present study did not collect information on when insomnia symptoms 
being reported emerged, information on when the history of reported sleep difficulties 
emerged was collected.  It was hypothesized that the majority of individuals who 
endorsed a history of sleep difficulties would indicate an onset of difficulties greater than 
six months prior.  As anticipated, among the 35.7% of individuals who reported a history 
of sleep difficulties, 88% reported an onset of over one year ago, with onset ranging from 
January of 1980 to January of 2008.  Information on the type of history of sleep 
difficulties being reported was also collected.  Savard and colleagues (2001) found that 
among breast cancer patients endorsing insomnia symptoms, 61% reported difficulties 
initiating sleep (sleep onset latency>30minutes), and 72% reported difficulty maintaining 
sleep (awake for>30 minutes at least once per week).   Among individuals endorsing 
insomnia disorder, 75% reported difficulties initiating sleep (sleep onset 
latency>30minutes), 86% reported difficulty maintaining sleep (awake for>30 minutes at 
least once per week), and 73% reported awakening too early (awake prior to desired time 
>30 minutes; Savard et al., 2001).  Given these findings we anticipated that, individuals 
would report a high level of all three difficulties, with maintenance being the most 
prevalent problem.  As predicted, maintenance was the most cited sleep difficulty among 
64 
 
 
our sample.  Among individuals who reported a history of sleep difficulties, 45.5% 
reported difficulties with maintenance and onset, 36.4% reported difficulties with 
maintenance, 13.6% reported difficulties with onset, and 4.5% reported difficulties with 
waking too early.   
Cancer Specific Stress 
 Differences by Cancer Type. Given that significant differences in insomnia 
severity were not found between breast cancer and other cancer types, investigations into 
potential differences in cancer specific stress were conducted.  Shapiro and colleagues 
(2001) highlighted findings that individuals with breast cancer on average report the 
highest level of stress relative to individuals with other cancer diagnoses.  This is 
potentially attributable to factors unique to breast cancer including the numerous 
challenges to body image, sexuality, fertility, and one’s overall sense of femininity (e.g. 
breast surgery, hair loss, early menopause).  Since the present study did not find 
significant differences in insomnia symptoms between individuals with breast cancer and 
individuals with other forms of cancer, we hypothesized that no significant difference 
would emerge between individuals with breast cancer compared to individuals with other 
forms of cancer on levels of cancer specific stress.    
Individuals with breast cancer were compared to individuals with other forms of 
cancer who participated in the larger study the present study was housed under.  Other 
forms of cancer individuals had included lung (n=12), gynecological (n=22), colon 
(n=12), lymphoma (n=5), and prostate (n=3).  Only one participant had liver cancer, 
therefore this was not included as a comparison group.  Due to the small sample sizes for 
other forms of cancer, presented findings should be interpreted with caution.   
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 As predicated, breast cancer patients did not report significantly higher levels of 
cancer specific stress relative to individuals with lung cancer, gynecological cancer, 
colon cancer, or prostate cancer (ps>.05).  However, some analyses did approach 
significance.  A trend emerged, with individuals with breast cancer endorsing less cancer 
specific stress relative to individuals with colon cancer, t(50)=-1.89, p=.06.  A trend 
emerged, with individuals with breast cancer endorsing less cancer specific stress relative 
to individuals with lymphoma, t(50)=-2.00, p=.05.  There was no significant difference 
between individuals with breast cancer and lung cancer, t(50)=1.19, p=.24.  There was no 
significant difference between individuals with breast cancer and gynecological cancer, 
t(50)=.42, p=.68.  There was no significant difference between individuals with breast 
cancer and prostate cancer, t(50)=.42, p=.68.  Means and standard deviations of each 
form of cancer for cancer specific stress can be found in Table 16. 
Types of Stressors.  Given the demonstrated relationship between cancer specific 
stress and symptoms of insomnia, individual questions from the QSCP-R were examined 
in relation to the ISI.  Several questions on the QSCP-R were entered into separate linear 
regressions to identify the contribution of each question in the variance of insomnia 
symptoms while controlling for appropriate covariates.  Surgery was included as a 
covariant for all regressions aside from the regression including the QSCP-R question on 
surgery.  The following four questions were included: I am suffering pain due to surgery; 
I feel physically imperfect; I do not feel well informed about my illness/treatment; I have 
too few opportunities to talk about emotional problems with a specialist.  Although 
research on the relationship between cancer treatments and insomnia yields inconsistent 
results (Davidson et al., 2002; Engstrom et al., 1999; Fortner et al., 2002; Savard et al., 
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2001), it was hypothesized that the stress of pain due to surgery would be associated with 
more insomnia symptoms.  This was hypothesized given the present study identified 
surgical treatment as a covariate of insomnia symptoms and cancer specific stress.  The 
question on body image was chosen given physical changes are a potential stressor 
unique to breast cancer treatment (For review, see Shapiro et al., 2001).  It was 
hypothesized that poor body image would be associated with more symptoms of 
insomnia.  The question on not feeling well informed about cancer and its associated 
treatments, was driven by previous findings that lower education level is associated with 
poorer QoL among breast cancer patients (Janz et al., 2005).  Moreover, it was 
hypothesized that individuals who did not feel well informed or who were not able to 
understand information and therefore felt poorly informed, were more likely to report 
symptoms of insomnia.  The question on the availability of mental health specialists was 
to identify whether a relationship exists between a perceived need among patients for 
more mental health support and insomnia symptoms.  It was anticipated that individuals 
who felt there was not an opportunity to speak with mental health care professionals 
would indicate more symptoms of insomnia.  It should be noted that the two sites where 
information was obtained houses a behavioral medicine department that is available to 
patients.   
Suffering surgical pain did not predict insomnia symptoms, t(54)=1.85, p=.07.  As 
hypothesized, more feelings of body imperfection predicted more insomnia symptoms, 
t(55)=4.80, p<.001, while controlling for surgery as a covariate.  As hypothesized, feeling 
less informed about one’s illness and associated treatments predicted greater insomnia 
symptoms, t(55)=2.62, p=.011, while controlling for surgery as a covariate.   As 
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predicted, having few opportunities to talk about emotional issues with a specialist 
predicted more symptoms of insomnia, t(55)=3.39, p=.001, while controlling for surgery 
as a covariate.   
In order to identify the relative contribution of each stressor found to be 
significant (I feel physically imperfect; I do not feel well informed about my 
illness/treatment; I have too few opportunities to talk about emotional problems with a 
specialist), a simultaneous linear regression was run.  While controlling for surgery as a 
covariate, the only stressor that remained significant was feelings of physical 
imperfection.  Therefore, while controlling for surgery as a covariate, feeling uninformed 
about illness/treatment, and having too few opportunities to speak with health care 
professionals, more feelings of physical imperfection predicted more symptoms of 
insomnia , t(55)=3.26, p<.002. 
Mindfulness 
 Mindfulness, as measured by the FFMQ, did not correlate with symptoms of 
insomnia.  Moreover, mindfulness did not moderate the relationship between insomnia 
symptoms and precipitating (history of sleep difficulties) or perpetuating factors (cancer 
specific stress).  To identify if specific factors of mindfulness were potentially associated 
with insomnia symptoms, the relative contributions of the five factors of mindfulness 
included in the FFMQ and the covariate surgery were entered into a linear regression 
simultaneously.  The five factors of mindfulness as delineated by Baer and colleagues 
(2008) include nonreactivity to inner experience (e.g. allowing thoughts and feelings to 
exist without becoming submerged in them), observing (e.g. having an awareness of 
internal and external stimuli), describing (e.g. the labeling of individual experiences with 
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language), acting with awareness (e.g. being in the present moment), and nonjudgmental 
of inner experience (e.g. not evaluating thoughts and feelings).  It was hypothesized that 
individuals who were more nonreactive, acted with awareness, and were nonjudgmental 
of inner experiences would endorse less symptoms of insomnia, while factors such as 
describing and observing would not be significant predictors of insomnia symptoms.  
This was proposed given nonreactivity, acting with awareness, and being nonjudgmental 
of inner experiences are likely to be deactivating processes, inversely associated with 
arousal thereby decreasing insomnia symptoms.  Although all factors of mindfulness are 
interrelated, observing and describing appear to have less of a direct connection with 
arousal.    
Nonreactivity to inner experiences was the only factor that predicted insomnia 
symptoms when controlling for surgery and all other mindfulness factors, t(53)=-2.58, 
p=.013, with greater reactivity predicting higher endorsement of insomnia symptoms.  
Observing, describing, acting with awareness, and nonjudgmental of inner experience, 
did not predict symptoms of insomnia (ps>.05).    Given these results, the nonreactivity 
subscale was entered into the originally proposed moderation analyses investigating the 
relationship between symptoms of insomnia and precipitating and perpetuating factors.  
Nonreactivity was not found to moderate the relationship between dysfunctional beliefs 
and attitudes about sleep and insomnia severity.  In addition, nonreactivity was not found 
to moderate the relationship between cancer specific stress and insomnia severity.  
 Although the AAQ-2 (aggregated score) and symptoms of insomnia did correlate, 
acceptance/psychological flexibility as measured via the AAQ-2 did not moderate the 
relationship between insomnia symptoms and precipitating or perpetuating factors.  To 
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better understand the interrelationship between variables, aspects of acceptance were 
investigated by the two subscales of the AAQ-2.  The acceptance subscale specifically 
investigates one’s ability to experience, without attempting to change the experience, 
therefore the opposite of experiential avoidance (Hayes et al., 1999).  The psychological 
flexibility subscale investigates the ability to live within one’s values without engaging in 
behaviors that are aimed at avoiding unpleasant experiences (Hayes et al., 1999).  It was 
hypothesized that higher scores on the acceptance subscale would predict insomnia 
severity while controlling for the psychological flexibility scale.  This hypothesis was 
driven by the potential role of acceptance in inhibiting increased arousal therefore 
decreasing insomnia by its inverse relationship with experiential avoidance.  
Psychological flexibility would hypothetically have a less direct relationship with 
arousal, therefore be a less robust predictor of insomnia.  Both subscales were entered 
simultaneously into a linear regression while covering for surgery.  Neither subscale of 
the AAQ-2 predicted insomnia symptoms when controlling for the other (ps>.05).  When 
entered individually into two linear regressions, both acceptance [t(54)=-3.06, p=.004] 
and psychological flexibility [t(54)=-2.64, p=.011] predicted insomnia severity while 
controlling for surgery. 
Dysfunctional Beliefs and Attitudes about Sleep 
Although dysfunctional beliefs and attitudes about sleep as measured by the 
DBAS-SF, did correlate with insomnia symptoms (p=.002), it was not found to contribute 
to the variance in symptoms of insomnia above and beyond predisposing and 
precipitating factors.  Given these findings, dysfunctional beliefs and attitudes about 
sleep were not found to be a significant perpetuating factor associated with insomnia 
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among individuals with breast cancer.  However, dysfunctional beliefs and attitudes in 
reference to insomnia symptoms and cancer (e.g. poor sleep will cause my cancer to 
return) have also been hypothesized as perpetuating factors unique to individuals with 
cancer (Savard & Morin, 2001).  This has not been empirically evaluated.  In order to 
explore this potential cancer specific factor, question number three on the DBAS-SF was 
evaluated (I am concerned that chronic insomnia may have serious consequences on my 
physical health) in relation to insomnia symptoms.  It was hypothesized that greater 
beliefs in insomnia having physical consequences would be associated with an increase in 
insomnia symptoms.  While controlling for covariates (marital status and surgical 
treatment), concern about the consequences of insomnia on physical health was 
predictive of insomnia severity, t(55)=2.34, p=.023.  Given this finding, concern about 
the consequences of insomnia on physical health was evaluated as a potential 
perpetuating factor within the three factor model.  A hierarchical regression was 
conducted to investigate this hypothesis.  Surgery and marital status were entered as 
covariates in the first step.  History of sleep difficulties was entered on the second step as 
a predisposing factor.  Cancer specific stress was entered on the third step as a 
precipitating factor.  Concern about the consequences of insomnia on physical health was 
entered on the fourth step as a potential perpetuating factor.  Concern about the 
consequences of insomnia on physical health did not significantly contribute to the 
variability in severity of insomnia symptoms above and beyond covariates, and 
predisposing and precipitating factors (p>.05).   
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CHAPTER 5:  DISCUSSION 
Findings from the present study suggest that symptoms of insomnia are prevalent 
among individuals with cancer, including breast cancer.  Specific predisposing and 
precipitating factors were found to account for insomnia symptoms among our sample of 
individuals with breast cancer.  Having a history of sleep difficulties was the only 
predisposing factor found to account for symptoms of insomnia.  In reference to 
precipitating factors, cancer specific stress contributed to the variance in insomnia 
symptoms above and beyond a history of sleep difficulties.  This is a novel finding, and 
to our knowledge, the relationship between cancer specific stress and insomnia has never 
been investigated or reported before in the literature.  Although dysfunctional beliefs and 
attitudes about sleep correlated with insomnia severity, they did not contribute to the 
variance in insomnia severity above and beyond predisposing or precipitating factors, and 
were therefore, not identified as a perpetuating factor of insomnia.  Although aspects of 
mindfulness did correlate with insomnia symptoms and cancer specific stress, 
mindfulness did not moderate the relationship between cancer specific stress and 
insomnia symptoms, or dysfunctional beliefs and attitudes about sleep and insomnia 
symptoms.  These findings aid in better understanding factors associated with insomnia 
symptoms among individuals with breast cancer and aid in directing future research.   
Insomnia Symptoms among Breast Cancer Patients 
 The present study replicated findings that insomnia symptoms are prevalent 
among individuals with breast cancer (Carlson et al., 2007; Davidson et al., 2001; Fortner 
et al., 2002; Koopman et al., 2002).  As projected, 48% of individuals in this sample 
indicated clinically significant levels of insomnia symptoms, consistent with Savard and 
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colleagues (2001) who found 51%.  Moreover, present findings may even underestimate 
the prevalence of insomnia symptoms given that some individuals who declined 
participation may have felt too sick to participate and may have endorsed even greater 
insomnia symptoms.  The history of sleep difficulties reported by individuals with breast 
cancer was often chronic, with 88% of individuals endorsing its onset dating back past 
one year.  In addition, the sleep difficulties were characterized mainly by a combination 
of maintenance and onset problems.   
Predisposing Factors 
 As anticipated, the present study identified a history of sleep difficulties as being 
associated with elevated symptoms of insomnia among breast cancer patients.  Savard 
and Morin (2001) proposed that a history of insomnia is a predisposing factor associated 
with comorbid insomnia in the context of cancer.  This too is consistent with Engstrom 
and colleagues (1999) who found that a history of a sleep disorder was a predisposing 
factor associated with insomnia among individuals with cancer.  Moreover, 67% of a 
breast cancer sample reported having sleep difficulties prior to the diagnosis of breast 
cancer, suggesting that past sleep problems, at least in part, are likely to predispose an 
individual to insomnia within the context of breast cancer (Savard et al., 2001).   Despite 
the present study having a lower prevalence of history of sleep difficulties (37.5%) 
relative to Savard and colleagues (2001), it remained prevalent and a significant 
predisposing factor associated with insomnia.  Findings suggest that a high percentage of 
individuals who develop breast cancer are predisposed to developing insomnia before 
even being diagnosed with cancer.  Therefore, the overall high prevalence of insomnia 
among individuals with breast cancer is not surprising.  Perhaps if medical providers 
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were aware of a newly diagnosed cancer patient’s history of sleep difficulties, this could 
be addressed prior to the cascade of precipitating factors such as cancer related stressors.  
By addressing the predisposing factor at the start, insomnia may be avoided.       
 Results from the present study in reference to additional proposed predisposing 
factors (age, symptoms of anxiety, and symptoms of depression) were not consistent with 
much of the research reviewed.  Most noteworthy is the failure to find a significant 
relationship between psychological factors and symptoms of insomnia.  Although higher 
levels of anxiety and depression correlated with greater endorsement of insomnia 
symptoms, neither symptoms of depression nor symptoms of anxiety were identified as 
predisposing factors associated with insomnia severity.  Psychological disorders have 
been consistently identified as having an association with insomnia symptoms among the 
general population, heterogeneous cancer populations, and breast cancer populations 
(Bardwell et al., 2008; Espie, 2002; Ford & Kamero, 1989; Hoehn-Saric, 1981; Palesh et 
al., 2007; Roth & Roehrs, 2003; Thase, 2005).  Given past research findings, Savard and 
Morin (2001) included psychiatric disorders as likely predisposing factors associated with 
comorbid insomnia among cancer patients.  The present study’s findings are puzzling, 
given our participants did not even endorse a significant amount of symptoms of 
depression or anxiety, with reported psychological symptoms similar to what is found in 
the general population.  One could argue that our sample had earlier stages of cancer with 
better prognoses which would potentially lead to less psychological symptoms; however, 
no relationship between primary variables and stage of cancer were significant.  The 
present sample may not have had a high enough level of anxiety or depression to 
influence sleep, or the variability in anxiety and depression may have been too limited to 
74 
 
 
detect an effect.  Although anxiety was normally distributed, it had a relatively restricted 
range.  In addition, there may not have been sufficient power to detect relationships of 
predisposing factors.  However, our sample did endorse a significant level of insomnia; 
therefore, findings suggest that anxiety and depression may not be a robust precipitating 
factor associated with insomnia severity among individuals with breast cancer.   
Age was not significantly associated with symptoms of insomnia.  Participants 
ranged in age from 26-75, allowing for ample variability and range.  Additionally, the age 
range was normally distributed (age 26-40 [n=10]; age 41-60 [n=34]; age 61-75 [n=12]).  
Significance was not found when age was investigated categorically either, but may have 
been undetectable because once age was divided into categories, the group size became 
small.  Past studies have yielded inconsistent findings in reference to the relationship 
between sleep and age among individuals with cancer.  Although some studies of cancer 
patients have found younger age to be associated with insomnia (Davidson et al., 2002) 
other researchers have found older age to be associated with insomnia (Engstrom et al., 
1999).  However, Bardwell and colleagues (2008) did not find any relationship between 
insomnia and age among a sample of 2,645 women treated for breast cancer.  Although 
age may not be a direct predisposing factor, Davidson and colleagues (2002) suggest that 
individuals who are younger may experience more stress when diagnosed with cancer.  
Factors such as fertility are likely to have greater implications for younger patients.  For 
example, a woman who is diagnosed with breast cancer at the age of 25 may be 
concerned about her ability to have children in the future, ability to care for young 
children, long term health concerns, and implications the cancer will have on a new 
career; where as an older women may not experience these stressors.  Therefore, another 
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explanation for the present study’s findings is that there were not enough younger 
patients with stressors such as young children or fertility concerns to identify statistical 
significance.  Perhaps a larger sample size would be better able to identify the effects of 
age on insomnia among individuals with breast cancer.  Nonetheless, present findings, 
coupled with the variability in previous findings suggest that age may not be a robust 
direct predisposing factor associated with insomnia among individuals with breast cancer.    
Precipitating Factors 
 Individuals exposed to stressors, such as stress related to breast cancer, are more 
likely to develop insomnia relative to the general population (National Heart, Lung, and 
Blood Institute, 1995; Sateia et al., 2000).   Morin and Savard (2001) proposed that stress 
associated with cancer is likely a precipitating factor associated with insomnia.  
Moreover, a longitudinal study demonstrated stress as a precipitator of insomnia 
symptoms among individuals with breast cancer (Palesh et al., 2007).  However, the 
direct relationship between cancer specific stress and symptoms of insomnia had not been 
explored. The novel investigations into cancer specific stress as a unique precipitating 
factor of insomnia symptoms in our sample did indeed reveal that cancer specific stress 
contributed to variability in insomnia severity above and beyond a history of sleep 
difficulties (predisposing factor).     
 Post-hoc analyses identified certain aspects of cancer specific stress to be more 
robustly associated with symptoms of insomnia relative to others.  Feeling uninformed 
about one’s illness and associated treatments, feelings of bodily imperfection, and feeling 
that there were limited opportunities to speak with specialists about emotional well-being 
were all associated with symptoms of insomnia among individuals with breast cancer.  
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However, feelings of body imperfection were the most robust factor associated with 
insomnia severity.  Such findings are consistent with QoL research, which discusses the 
potential impact of breast cancer and associated treatments to an individual’s identity as a 
female (Shapiro et al., 2001).  The effects of treatments such as mastectomies and 
chemotherapy can change one’s physical appearance and challenge societal views of 
beauty.  Moreover, the manner in which an individual once saw themselves has changed, 
their previous sense of self challenged.  One might develop insomnia due to ruminative 
thoughts and cognitive arousal, thinking about the physical alterations and change in 
one’s view of themselves.  Moreover, the relationship may be more indirect, with 
concerns about physical alterations creating marital stress, thereby creating a decrease in 
social support and an increase in stressors.   Likewise, the physical alterations could act 
as reminders of mortality.  As stressors increase, cognitive arousal may increase, and an 
individual who is already predisposed to sleep difficulties may develop insomnia.   
Given the potential uniqueness in this stressor, one may anticipate that breast 
cancer patients experience insomnia differently relative to individuals with other forms of 
cancer.  However, there was no difference in cancer specific stress experienced between 
cancer types.  As previously discussed, this may help clarify why there were not 
differences between cancer type and insomnia severity within our sample.  Moreover, it 
was anticipated that cancer specific stressors unique to breast cancer would contribute to 
differences between cancer types, such as the numerous challenges to body images, 
sexuality, fertility, and one’s overall sense of femininity (e.g. breast surgery, hair loss, 
early menopause) that are associated with breast cancer.  For that reason, the question 
investigating feelings associated with physical imperfections was evaluated 
77 
 
 
independently in the post-hoc analyses.  Feelings associated with physical imperfections 
did emerge as a predictor of insomnia among individuals with breast cancer.  However, 
there was no difference between types of cancer and feelings associated with physical 
imperfections.  Two possibilities emerge.  One being that changes in physical appearance 
are associated with other forms of cancer in the same manner as it is associated with 
breast cancer (e.g. chemotherapy and hair loss).  Another possibility leads back to the 
small sample size in the groups of other cancer types.  Therefore, future studies are 
needed to truly identify whether or not individuals with different forms of cancer 
experience different types of stressors associated with cancer that are related to insomnia 
severity.   
Perpetuating Factors 
 Dysfunctional beliefs and attitudes about sleep did correlate with insomnia 
symptoms, yet did not account for variability in insomnia symptoms above and beyond 
the predisposing factor of a history of sleep difficulties or the precipitating factor of 
cancer specific stress.  Savard and Morin (2001) suggested that individuals with cancer 
who experience chronic insomnia may be engaging in activities that are not compatible 
with sleep, such as watching television in bed.  These activities were proposed as 
potentially contributing to the maintenance of sleep dysfunction by weakening the 
connection between one’s place of sleep and the actual act of sleeping (Morin, 1993).  
Dysfunctional cognitions in reference to sleep and cancer (e.g. poor sleep will cause my 
cancer to return) have also been hypothesized as perpetuating factors unique to 
individuals with cancer (Savard & Morin, 2001).  However, the anticipated relationship 
between general dysfunctional beliefs and attitudes about sleep and insomnia was not 
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supported by present findings.  Interestingly, although our sample was normally 
distributed, individuals had significantly higher endorsement of dysfunctional beliefs and 
attitudes about sleep relative to published norms for both a nonclinical group and 
individuals with insomnia (Rumble et al., 2005).  Therefore, one would expect that if 
dysfunctional beliefs and attitudes about sleep were a strong perpetuating factor of 
insomnia among individuals with breast cancer, a relationship would have emerged in our 
sample.   
 An alternative explanation for results is that beliefs about sleep may have less of a 
role in the cycle of insomnia among breast cancer patients relative to individuals with 
insomnia in the general clinical insomnia population. The chronicity of insomnia among 
individuals with breast cancer may not be long enough to have perpetuating factors 
emerge.  However, Savard and colleagues (2001) found that among individuals with 
breast cancer endorsing insomnia, 95% endorsed chronic insomnia.  Although our study 
cannot report on the chronicity of the insomnia specifically, among individuals who 
reported a history of sleep difficulties, the difficulties began over one year ago for 88% of 
breast cancer patients.  Moreover, individuals in the present sample did endorse a high 
level of dysfunctional beliefs and attitudes about sleep suggesting that if the relationship 
was present, it would have emerged.   
Another hypothesized explanation is that individuals with cancer are more 
engaged in dysfunctional beliefs and attitudes about sleep associated with their cancer, 
such as concerns about poor sleep impacting recovery from cancer.  This was initially 
proposed by Savard and Morin (2001) and lead to the investigation into a specific DBAS-
SF question (I am concerned that chronic insomnia may have serious consequences on 
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my physical health).  Although concerns about the medical implications of insomnia did 
correlate with insomnia symptoms, it did not predict insomnia above and beyond 
predisposing and precipitating factors.  Therefore, a dysfunctional belief about insomnia 
and physical well being was not found to perpetuate the insomnia in the present study’s 
sample.  However, interpretations should be made with caution given only one question 
was included in the analyses and it did not directly address cancer.  Future studies should 
aim to better identify the relationship between breast cancer and dysfunctional beliefs and 
attitudes about sleep specific to cancer.  
An alternative thought is that cancer specific stress is both a precipitating and 
perpetuating factor which trumps the influences of dysfunctional beliefs and attitudes 
about sleep.  The stress of cancer is often a constant and multifaceted group of issues, 
with treatment, physical changes, and issues of employment emerging throughout the 
process.  For example, an individual may get diagnosed with breast cancer, starts 
treatment one month later, have issues with employment emerge one year later due to 
taking leave, and continue on a path of new stress associated with the breast cancer.  
Perhaps this series of stressors is both a robust precipitating factor and perpetuating factor 
among breast cancer patients.  Dysfunctional beliefs and attitudes about sleep may 
remain a perpetuating factor among the general population because the stress of cancer is 
not a factor.   
Mindfulness and Symptoms of Insomnia 
 The investigation of mindfulness and symptoms of insomnia among individuals 
with breast cancer was a novel conceptual approach to a complex problem.  Contrary to 
what was expected, mindfulness conceptualized as a singular global construct, was not 
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associated with insomnia as a moderator among individuals with breast cancer.  
Moreover, the global construct of mindfulness did not correlate with insomnia symptoms.    
However, aspects of mindfulness such as acceptance and nonreactivity, did correlate with 
insomnia among breast cancer patients.  These findings lead one to question how 
mindfulness should be conceptualized and what role mindfulness has in the context of 
insomnia.  
The investigation into the relationship between the global construct of 
mindfulness and symptoms of insomnia was motivated by Lundh’s (2000; 2005) 
conceptualization of insomnia incorporating aspects of mindfulness.  Lundh’s (2000; 
2005) theory of insomnia suggests that heightened mindfulness likely reduces cognitive 
and physiological arousal since these constructs are mutually exclusive.  In addition, Ong 
and colleagues (2008) found that increased mindfulness meditation leads to both 
decreased arousal and decreased symptoms of insomnia.  Lundh’s (2000; 2005) theory 
and Ong and colleagues (2008) findings contributed to the present study’s hypotheses 
that mindfulness may change the relationship between symptoms of insomnia and 
precipitating and perpetuating factors.   
Cancer Specific Stress and Mindfulness 
The individual aspects of mindfulness that were associated with symptoms of 
insomnia in the present study were acceptance – that is acceptance of thoughts as 
thoughts and emotions as emotions, and being nonreactive – that is, one’s ability to 
remain nonreactive to inner experiences.  It was hypothesized that higher endorsement of 
the global trait of mindfulness would change the relationship between cancer related 
stress and insomnia severity.  Moreover, if one has the stress of cancer, but remains 
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nonreactive and accepting, their sleep is more likely to be preserved given they will not 
become aroused.  Although greater nonreactivity and acceptance did correlate with fewer 
insomnia symptoms and less cancer specific stress, the moderation did not emerge.  
Mindfulness-based interventions have been shown to decrease stress and improve sleep 
quality among cancer populations (for review, see Smith, 2005), including breast cancer 
populations (Carlson et al., 2003).  But present findings suggest that it may not be as 
simple as being high on the global trait of mindfulness, and that changing the impact of 
stress, and thereby, decreases insomnia severity.  One possibility is that the relationship is 
more specific and more direct.  Perhaps only certain aspects of mindfulness such as 
nonreactivity and acceptance directly influence insomnia.  Therefore, when mindfulness 
is investigated as a global construct or as a moderator, significance would not be found.  
Perhaps it is simply that nonreactivity and acceptance decrease cognitive arousal and 
therefore decrease insomnia symptoms.    
Another possibility is that the decrease in insomnia symptoms observed in MBSR 
interventions or interventions that include mindfulness meditation (Ong et al., 2008), are 
not attributable to an increase in the global trait of mindfulness.  Perhaps these changes 
are attributable to other aspects of the intervention that are independent of mindfulness.  
This may explain why when researchers included an attention placebo group, individuals 
in the MBSR group were not found to have a significantly different improvement in sleep 
quality relative to the attention placebo group (Shapiro et al., 2003).  Therefore, other 
elements of MBSR, such as psycho-education or relaxation, may be the mechanism by 
which insomnia symptoms dissipate.   Another possibility is that the practice of 
mindfulness meditation may be contributing to the decrease in stress and decrease in 
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insomnia symptoms within mindfulness based interventions (Carlson et al., 2003; Carlson 
& Garland 2005; Ong et al., 2008).  This may explain why only two factors of 
mindfulness, and not mindfulness as a whole, emerged as significantly being associated 
with insomnia and cancer specific stress.  Perhaps nonreactivity and acceptance are 
constructs that are more highly associated with the act of mindfulness meditation.  When 
an individual engages in mindfulness meditation perhaps the most influenced trait of 
mindfulness is nonreactivity and acceptance.   Being that nonreactivity is likely to have 
an association with arousal, this could explain the decrease in insomnia symptoms.  
However, nonreactivity or acceptance were not found to moderate the relationships 
between cancer specific stress and insomnia symptoms.  Such findings suggest that 
perhaps aspects of mindfulness do not change the relationship between stress and 
insomnia, but are interrelated to insomnia in a different manner.  Perhaps higher 
nonreactivity decreases arousal, which increases acceptance, therefore changing the 
impact of stress on insomnia symptoms.  Future studies may be able to identify this better 
by separating the act of mindfulness meditation and the trait of mindfulness apart.  
Additionally, future research on insomnia interventions that include a mindfulness 
component should evaluate the trait of mindfulness before and after treatment to identify 
changes.  This may aid in identifying shifts in mindfulness associated with treatment and 
insomnia severity.  
Dysfunctional Beliefs and Attitudes about Sleep and Mindfulness 
Mindfulness as measured by the AAQ-2 or FFMQ was not found to moderate the 
relationship between dysfunctional beliefs and attitudes about sleep and symptoms of 
insomnia.  Moreover, mindfulness and acceptance did not correlate with dysfunctional 
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beliefs and attitudes about sleep.  Lundh (2000) suggests that insomnia exists at an 
interface, that being, the interrelationship between processes that are not compatible with 
sleep (e.g. cognitive and physiological arousal) and the manner in which one identifies 
with sleep (e.g. attribution and beliefs).  Heightened mindfulness was proposed to reduce 
cognitive and physiological arousal given that these constructs are unable to be 
experienced simultaneously.  One cannot engage in a mindful, accepting and cognitively 
deactivated state of being, while aroused (Lundh, 2000).  Moreover, one would be less 
impacted by dysfunctional beliefs and attitudes about sleep if they were more mindful 
because they would not become as aroused.  The present study failed to confirm this 
connection.  It is possible that the relationship between dysfunctional attitudes and beliefs 
about sleep is less robust among individuals with cancer.  Ong and colleagues (2008) 
were not investigating cancer patients.  Moreover, as previously discussed, the stress 
associated with cancer may be such a strong precipitant that it washes out the effects of 
dysfunctional beliefs and attitudes, minimizing the importance of associated 
relationships.  However, Ong and colleagues (2008) found that the number of times an 
individual engaged in mindfulness meditation did not correlate with dysfunctional beliefs 
and attitudes about sleep.  Therefore, mindfulness may not change the relationship 
between dysfunctional beliefs and attitudes about sleep and insomnia severity among 
individuals with breast cancer.   
Limitations 
The strengths of this study are that it utilizes a clinical population comprised of 
breast cancer patients and implements standardized measures.  In doing so, the present 
study allows for conclusions to be drawn in reference to symptoms of insomnia and its 
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associated factors among individuals with breast cancer.  However, a number of 
limitations are acknowledged to help guide future research in this area.   
The absence of objective sleep measurements is one such limitation.  The present 
study focused on the subjective experience of sleep in order to make conclusions about 
the experience of symptoms of insomnia rather than the physiology of insomnia among 
individuals with breast cancer.  Given that the study aims to understand subjective sleep 
quality and the distress associated, objective measures of sleep were not deemed crucial 
in this preliminary study.  However, future studies may gain more insight into the 
physiology of insomnia among individuals with breast cancer by including objective 
measures of sleep.   
The use of an outpatient breast cancer sample may limit the ability to generalize 
findings to individuals with cancer who are hospitalized or receiving at home care.  
However, our results do suggest that findings may be generalizable to individuals with 
other forms of cancer, given that breast cancer patients indicated comparable levels of 
insomnia symptoms and cancer specific stress relative to individuals with other forms of 
cancer (lung, lymphoma, gynecological, colon, and prostate).  Generalizability may also 
be compromised given the depression scale was not evenly distributed and our sample 
failed to endorse a clinically significant amount of psychological distress which is 
inconsistent with past studies.   Future studies should aim to explore the differences in the 
experience of insomnia between individuals with different forms of cancer and while 
being hospitalized or receiving at home care.  The present study may not have had 
adequate sample sizes to identify differences between cancer types and did not include 
participates that were hospitalized or receiving at home care.  
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All factors potentially associated with insomnia among individuals with breast 
cancer were not assessed.  Menopausal status may be a factor worthy of exploration.  
Although the present study did not find an association between hormone replacement 
therapy and insomnia, menopausal status was not evaluated.  In addition, dysfunctional 
beliefs and attitudes about sleep specific to the experience of breast cancer would be 
worthy of future study.  Although dysfunctional beliefs and attitudes about sleep were not 
found to perpetuate insomnia, dysfunctional beliefs and attitudes about sleep specific to 
breast cancer was not adequately investigates.  One question on the DBAS-SF did 
address this by asking about one’s belief that insomnia causes poorer physical health, but 
because it is only one question it yields poor construct validity.  Future research should 
aim to explore explicit dysfunctional beliefs and attitudes about sleep specific to breast 
cancer, such as asking if they believe poor sleep will cause them to have more unpleasant 
side effects from chemotherapy, or not being able to sleep will cause immunosuppression 
when their immune system is already suppressed due to treatments such as 
chemotherapy.   Lastly, cognitive arousal was not evaluated in the present study.   Future 
studies should aim to include a measure of cognitive arousal in order to understand the 
pathway to which predisposing and precipitating factors influence insomnia.   In addition, 
ascertaining the relationship between cognitive arousal and mindfulness may aid in 
understanding the role mindfulness has in the cycle of insomnia. More research is needed 
to understand the multitude of factors potentially associated with insomnia among 
individual with breast cancer. 
It is also important to distinguish that the trait, not the practice, of mindfulness 
meditation was explored.  Future studies, such as research in MBSR, should examine the 
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practice of mindfulness meditation as a potential factor associated with insomnia.  By 
developing a better understanding of moderating factors, more efficacious treatments can 
be implemented.   
Additionally, the present study is correlational, and one cannot make conclusions 
in reference to causation.   Although cancer specific stress emerged as being a significant 
factor in understanding symptoms of insomnia among individuals with breast cancer, 
current findings cannot be used to indicate that cancer specific stress causes symptoms of 
insomnia. It is plausible that difficulty sleeping may increase one’s cancer related 
distress.  However, present findings in conjuncture with previously proposed theoretical 
models (for a review, see Perlis et al., 2005; Savard & Morin, 2001; Spielman et al.,1987; 
Spielman & Glovinsky, 1991) do suggest predisposing (history of sleep disorder) and 
precipitating (cancer specific stress) factors.  Longitudinal or intervention studies may aid 
in better understanding the potential causal relationship between factors.   
Implications 
The present study supports past findings that symptoms of insomnia are prevalent 
among breast cancer patients (Carlson et al., 2007).  Moreover, insomnia has been cited 
by individuals with cancer as impacting many dimensions of QoL, including an 
individual’s overall physical and emotional functioning (Davidson et al., 2002).  Such 
findings highlight the importance of investigating factors associated with symptoms of 
insomnia within breast cancer patients.   
The present study highlights the importance of history of sleep difficulties as a 
predisposing factor and cancer specific stress as a precipitating factor associated with 
insomnia severity among individuals with breast cancer.  Interventions developed to 
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address insomnia among the general population may need to be tailored for breast cancer 
patient populations to focus on predisposing and precipitating factors that emerge within 
this population.  For example, dysfunctional beliefs and attitudes about sleep is an 
important perpetuating factor associated with insomnia among the general population, but 
our sample failed to demonstrate dysfunctional beliefs and attitudes about sleep as a 
perpetuating factor.  In addition, cancer specific stress is a precipitating factor that houses 
many stressors over a period of time (e.g. diagnosis, treatments, physical changes due to 
treatment, employment issues) potentially maintaining an insomnia.  In the general 
population the precipitating factor may be a single event, such as the death of a family 
member.   
These findings aid in developing better ways to address symptoms of insomnia 
among breast cancer populations.  Past research coupled with present findings suggest 
that a history of sleep difficulties predisposes an individual to develop symptoms of 
insomnia when in the context of breast cancer.  Given such findings it may be of utility to 
evaluate breast cancer patients for a history of sleep difficulties when initially diagnosed 
with breast cancer.  Spending more time addressing potential issues of insomnia among 
patients with a history of sleep disorders may aid in decreasing the likelihood of future 
symptoms of insomnia.  In addition, many of the stressors that were noted by breast 
cancer patients could potentially be socially or environmentally mediated, such as 
psychological interventions to address body image issues associated with cancer 
treatment.  Identifying ways to address the stress specifically associated with cancer (e.g. 
body image concerns) may be beneficial in decreasing insomnia severity.  Such 
interventions may aid in alleviating associated stress.  Additional services may be 
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beneficial, such as consultation liaison services to address concerns about conflicting 
information from the medical team and clarify information, availability of occupational 
therapy to aid in managing self care, and accessibility of social work and rehabilitation 
psychology to aid in addressing vocational concerns.  Focusing on these specific factors, 
opposed to general dysfunctional beliefs and attitudes about sleep, appear to be more 
appropriate for breast cancer patients according to the present study’s findings.   
Additional research is needed to better understand the relationship between 
mindfulness and insomnia among breast cancer patient populations.  Findings in 
reference to mindfulness did not conclusively suggest whether MBSR or other 
mindfulness based treatments are appropriate for addressing issues of insomnia among 
individuals with breast cancer nor clarify how mindfulness is related to insomnia 
severity.  Although aspects of mindfulness were associated with symptoms of insomnia 
(nonreactivity and acceptance), nonreactivity and acceptance failed to moderate the 
relationship between cancer specific stress and symptoms of insomnia or dysfunctional 
beliefs and attitudes and sleep and insomnia severity.  Such findings highlight the 
importance in controlled randomized trials to identify why MBSR treatments have aided 
some individuals in decreasing symptoms of insomnia and what role mindfulness has in 
these changes.  Investigating both the trait of mindfulness separately from the act of 
mindfulness meditation may also aid in understanding the role.  Although aspects of 
mindfulness are likely associated with insomnia among individuals with cancer, the 
means to which these two constructs are linked requires additional research. 
Perhaps research would be better served by starting with a qualitative approach to 
investigating the three factor model of insomnia within breast cancer patient populations.  
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Such research should include the relationship between symptoms of insomnia and cancer 
specific stress.  Qualitative means would aid in exploring potential concerns over 
mortality and the experience of pain.  Although the present study did include these 
factors, they were explored via one or two questions on the measure of cancer specific 
stress.  Qualitative means would aid in understanding the role of existential concerns 
among breast cancer patients, such as worry about who will take care of their small 
children should they not survive.  Pain is also a multifaceted construct that could be 
explored in more depth, such as the type of pain, and chronicity of pain.  In addition, pain 
can often be a reminder of one’s illness.  Such qualitative analyses would allow for an 
exploration into the actual impact breast cancer has on one’s sense of self given all these 
factors.  Identifying how cancer specific stressors play a role in an individual’s life may 
help identify future directions for quantitative research.  Given findings from the present 
study, further investigations into cancer specific stress may aid in understanding co 
morbid insomnia in the context of breast cancer.  
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APPENDIX A: Demographic Questionnaire 
 
 
 
 
ID#________________ 
 
Date of Participation________________________ 
 
Please help us to gain a better understanding of who you are by completing this short 
demographics scale.  Place a check next to, or circle, the answer that you feel best 
describes yourself and your needs. If you do not feel that you fit into any of the categories 
listed, write in your answer. Thank you.  
 
1. What is your age? _____ 
  
2. What is your ethnicity or racial background?  
 
___White ___Asian ___Black ___Hispanic ___Other (________) 
  
3. Are you a U.S. born citizen?  
 
_____ YES         _____NO  (If not, in what country were you born?___________) 
         
4. Were you raised in the U.S.?  
 
       _____YES         ______NO  (If not, where were you raised?______________) 
 
5. If you were not raised in the U.S., at what age did you move to the U.S?_____ 
  
6. What type of cancer do you have?                        
 
____Breast     ____Colon  ____Prostate 
       ____Gynecological ____Lymphoma         ____Other:________________ 
 
7. Do you have metastatic disease? 
 
______ YES______ NO 
 
8. What type of treatment are you receiving? (Please check all that apply). 
 
___Radiation ___Chemotherapy ___ Hormonal Treatment  ___Surgery 
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APPENDIX A: Demographic Questionnaire (continued) 
 
 
 
If applicable: What types of surgical procedures have you had as part of cancer 
treatment?  
________________________________________________________ 
________________________________________________________ 
 
9. If you have completed your cancer treatment and are currently attending follow-
up appointments, please check how long it has been since completing your 
treatment: 
 
____ 0-6 months ____ 6 months- 1 year      _____ Greater than 1 year 
 
10. What is your marital status? 
 
 ____Single     ____Separated ____In a significant relationship 
 ____Married  ____Widowed  
 ____Divorced 
 
11. Do you currently live with anyone?  Yes     No 
 
 If yes, with whom?  ____Husband 
    ____Significant other 
    ____Parents 
    ____Sibling(s) 
    ____Other ___________________ 
 
 
12. Do you have children?    Yes     No 
 
 If yes, how many? _____________ 
 
What are their ages? ___________ 
 
If you are a female, did you breast feed? ___________ 
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APPENDIX A: Demographic Questionnaire (continued) 
 
13. What is your education level? 
 ___Less than high school - number of years you attended school = ___ 
___High School     
___Completed Trade School 
 ___Some College      
___Graduated College - 2 year 
___Graduated College - 4 year 
___Graduate School – Masters 
___Graduate School – Doctorate  
 
14. What is your job status?  
 
 ___Full-time  ___Student 
 ___Part-time  ___Unemployed 
 ___Homemaker ___Other______________ 
 ___Retired 
 
15. Do you have health insurance?  
____No  
 
 ____Yes, I have…. 
  ___Private 
  ___HMO (Health Maintenance Organization) 
  ___PPO (Preferred Provider Organization) 
  ___Partial Year: Specify ____________________ 
  ___Full Year: Specify ______________________ 
 
16. What is your religious affiliation? 
 
 ____Catholic  ____Baptist 
 ____Protestant ____None  
 ____Jewish          Other_______________ 
 ____Muslim  
 
17. What is your family income? 
 
  ____Less than 5,000  ____12,000 – 15,999 ____36,000 – 45,999. 
  ____5,000 – 7,999 ____16,000 – 24,999 ____46,000 – 50,000 
  ____8,000 – 11,999 ____25,000 – 35,999  ____Over 50,000 
 
18. Please list any additional medical problems you may be experiencing: 
_______________________________________________________________ 
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APPENDIX B:  Acceptance and Action Questionnaire-2 (AAQ-2) 
 
 
 
      Below you will find a list of statements. Please rate how true each statement is for     
          you by circling a number next to it. Use the scale below to make your choice. 
 
1 2 3 4 5 6 7 
Never 
 True 
very 
seldom true 
seldom  
true 
sometimes  
true 
frequently  
true 
almost 
always true 
always  
true 
       
1. Its OK if I remember something unpleasant. 1 2 3 4 5 6 7 
2. My painful experiences and memories make it 
difficult for me to live a life that I would value. 1 2 3 4 5 6 7 
3. I’m afraid of my feelings. 1 2 3 4 5 6 7 
4. I worry about not being able to control my worries and 
feelings. 
1 2 3 4 5 6 7 
5. My painful memories prevent me from having a 
fulfilling life. 1 2 3 4 5 6 7 
6. I am in control of my life. 1 2 3 4 5 6 7 
7. Emotions cause problems in my life. 1 2 3 4 5 6 7 
8. It seems like most people are handling their lives 
better than I am. 
1 2 3 4 5 6 7 
9. Worries get in the way of my success. 1 2 3 4 5 6 7 
10. My thoughts and feelings do not get in the way of how 
I want to live my life. 
1 2 3 4 5 6 7 
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APPENDIX C:  Dysfunctional Beliefs and Attitudes about Sleep- Short Form 
 
 
 
 
Several statements reflecting peoples’ beliefs and attitudes about sleep are listed below. 
Please indicate to what extent you personally agree or disagree with each statement. 
There is no right or wrong answer. For each statement, place a mark (/) along the line 
wherever your personal rating falls. Try to use the whole scale, rather than placing your 
marks at one end of the line. 
 
1) I need 8 hours of sleep to feel refreshed and function well during the day. 
 
 Strongly Strongly 
 disagree agree 
 
 
2) When I don’t get the proper amount of sleep on a given night, I need to catch up 
on the next day by napping or one the next night by sleeping longer. 
 
 Strongly Strongly 
 disagree agree 
 
 
3) I am concerned that chronic insomnia may have serious consequences on my 
physical health. 
 
 Strongly Strongly 
 disagree agree 
 
 
4) When I have trouble getting to sleep, I should stay in bed and try harder. 
 
 Strongly Strongly 
 disagree agree 
 
 
5) I am worried that I may lose control over my abilities to sleep. 
 
 Strongly Strongly 
 disagree agree 
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APPENDIX C:  Dysfunctional Beliefs and Attitudes about Sleep- Short Form 
(continued) 
 
 
 
 
6) After a poor night’s sleep, I know that it will interfere with my daily activities on 
the next day. 
 
 Strongly Strongly 
 disagree agree 
 
7) When I feel irritable, depressed, or anxious during the day, it is mostly because I 
did not sleep well the night before. 
 
 Strongly Strongly 
 disagree agree 
 
 
8) When I sleep poorly on one night, I know it will disturb my sleep schedule for the 
whole week. 
 
 Strongly Strongly 
 disagree agree 
 
 
9) When I feel tired, have no energy, or just seem not to function well during the 
day, it is generally because I did not sleep well the night before. 
 
 Strongly Strongly 
 disagree agree 
 
 
10) I get overwhelmed by my thoughts at night and often feel I have no control over 
this racing mind. 
 
 Strongly Strongly 
 disagree agree 
 
 
 
 
 
 
Adapted from:  Morin, C.M. (1993). Insomnia: Psychological Assessment and Management. New York: Guilford Press. 
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APPENDIX D:  Five Facet Mindfulness Questionnaire 
 
 
 
 
Please rate each of the statements below using the scale provided. Circle the number that 
best describes your own opinion of what is generally true of you. 
 
 
 1               2                3              4             5 
         Never or            Rarely true         Sometimes true        Often true         Very often or 
         rarely true                always true 
 
1. I perceive my feelings and emotions without having to react to them ……………… 1 2 3 4 5 
 
2. I watch my feelings without getting lost in them …………………………………… 1 2 3 4 5 
 
3. In difficult situations, I can pause without immediately reacting …………………... 1 2 3 4 5 
 
4. Usually when I have distressing thoughts or images, I am able to just notice them  
without reacting ……………………………………………………………………… 1 2 3 4 5 
 
5. Usually when I have distressing thoughts or images, I feel calm soon after ………… 1 2 3 4 5 
 
6. Usually when I have distressing thoughts or images, I “step back” and am aware of  
the thought or image without getting taken over by it………………………………… 1 2 3 4 5 
 
7. Usually when I have distressing thoughts or images, I just notice them and let  
them go ……………………………………………………………………………….. 1 2 3 4 5 
 
8. When I’m walking, I deliberately notice the sensations of my body moving ……….. 1 2 3 4 5 
 
9. When I take a shower or a bath, I stay alert to the sensations of water on my body … 1 2 3 4 5 
 
10. I notice how foods and drinks affect my thoughts, bodily sensations, and emotions .. 1 2 3 4 5 
 
11. I pay attention to sensations, such as the wind in my hair and sun on my face ……… 1 2 3 4 5 
 
12. I pay attention to sounds, such as clocks ticking, birds chirping, or cars passing …… 1 2 3 4 5 
 
13. I notice the smells and aromas or things……………………………………………… 1 2 3 4 5 
 
14. I notice visual elements in art or nature, such as colors, shapes, textures, or patterns 
of light and shadow …………………………………………………………………. 1 2 3 4 5 
 
15. I pay attention to how my emotions affect my thoughts and behavior ……………… 1 2 3 4 5 
 
16. I find it difficult to stay focused on what’s happening in the present ………………... 1 2 3 4 5 
 
17. It seems I am “running on automatic” without much awareness of what I’m doing ….1 2 3 4 5 
 
 
18. I rush through activities without being really attentive to them ……………………… 1 2 3 4 5 
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APPENDIX D:  Five Facet Mindfulness Questionnaire (continued) 
 
 
 
 
 1               2                3              4             5 
         Never or            Rarely true         Sometimes true        Often true         Very often or 
         rarely true                always true 
  
19. I do jobs or tasks automatically, without being aware of what I’m doing ……………. 1 2 3 4 5 
 
20. I find myself doing things without paying attention ………………………………….. 1 2 3 4 5 
 
21. When I do things, my mind wanders off and I’m easily distracted ……………………1 2 3 4 5 
 
22. I don’t pay attention to what I’m doing because I’m daydreaming, worrying, or  
otherwise distracted …………………………………………………………………. 1 2 3 4 5 
 
23. I am easily distracted ……………………………………………………………….. 1 2 3 4 5 
 
24. I’m good at finding the words to describe my feelings …………………………….. 1 2 3 4 5 
 
25. I can easily put my beliefs, opinions, and expectations into words ………………… 1 2 3 4 5 
 
26. It’s hard for me to find the words to describe what I’m thinking ………………….. 1 2 3 4 5 
 
27. I have trouble thinking of the right words to express how I feel about things …….. 1 2 3 4 5 
 
28. When I have a sensation in my body, it’s hard for me to describe it because I can’t 
find the right words ………………………………………………………………… 1 2 3 4 5 
 
29. Even when I’m feeling terribly upset, I can find a way to put it into words ………. 1 2 3 4 5 
 
30. My natural tendency is to put my experiences into words ………………………… 1 2 3 4 5 
 
31. I can usually describe how I feel at the moment in considerable detail …………… 1 2 3 4 5 
 
32. I criticize myself for having irrational or inappropriate emotions …………………. 1 2 3 4 5 
 
33. I tell myself that I shouldn’t be feeling the way I’m feeling ………………………. 1 2 3 4 5 
 
34. I believe some of my thoughts are abnormal or bad and I shouldn’t think that way.. 1 2 3 4 5 
 
35. I make judgments about whether my thoughts are good or bad ………………….. 1 2 3 4 5 
 
36. I tell myself I shouldn’t be thinking the way I’m thinking …………………………. 1 2 3 4 5 
 
37. I think some of my emotions are bad or inappropriate and I shouldn’t feel them ….. 1 2 3 4 5 
 
38. I disapprove of myself when I have irrational ideas ………………………………… 1 2 3 4 5 
 
39. Usually when I have distressing thoughts or images, I judge myself as good or bad,  
depending what the thought/image is about ………………………………………… 1 2 3 4 5 
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APPENDIX E:  Hospital Anxiety and Depression Inventory 
 
 
 
Instructions: Please read each statement carefully and circle the answer which best 
describes how you feel.  
 
1. I feel tense or “wound up”. 
a. Most of the time 
b. A lot of the time 
c. From time to time, occasionally 
d. Not at all 
 
2. I still enjoy the things I used to enjoy. 
a. Definitely as much 
b. Not quite as much 
c. Only a little 
d. Hardly at all 
 
3. I get a sort of frightened feeling as if something awful is about to happen. 
a. Very definitely and quite badly 
b. Yes, but not too badly 
c. A little, but it doesn’t worry me 
d. Not at all 
 
4. I can laugh and see the funny side of things. 
a. As much as I always could 
b. Not quite so much now 
c. Definitely not so much now 
d. Not at all 
 
5. Worrying thoughts go through my mind. 
a. A great deal of the time 
b. A lot of the time 
c. From time to time but not too often 
d. Only occasionally 
 
6. I feel cheerful. 
a. Not at all 
b. Not often 
c. Sometimes 
d. Most of the time 
 
      7. I can sit at ease and feel relaxed. 
a. Definitely 
b. Usually 
c. Not often 
d. Not at all 
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APPENDIX E:  Hospital Anxiety and Depression Inventory (continued) 
 
 
 
 
8. I feel as if I am slowed down. 
a. Nearly all the time 
b. Very often 
c. Sometimes 
d. Not at all 
 
9. I get a sort of frightened feeling like “butterflies” in the stomach. 
a. Not at all 
b. Occasionally 
c. Quite often 
d. Very often 
 
10. I have lost interest in my appearance. 
a. Definitely 
b. I don’t take so much care as I should 
c. I may not take quite as much care 
d. I take just as much care as ever 
 
11. I feel restless as if I have to be on the move. 
a. Very much indeed 
b. Quite a lot 
c. Not very much  
d. Not at all 
 
12. I look forward with enjoyment to things. 
a. As much as I ever did 
b. Rather less than I used to 
c. Definitely less than I used to 
d. Hardly at all 
 
13. I get sudden feelings of panic. 
a. Very often indeed 
b. Quite often 
c. Not very often  
d. Not at all 
 
14. I can enjoy a good book or radio or TV program. 
a. Often 
b. Sometimes 
c. Not often 
d. Very seldom 
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APPENDIX F:  Insomnia Severity Index 
 
 
 
 
1. Please rate the current SEVERITY of your insomnia problem(s) in the 
past MONTH. 
 
                      
    None        Mild        Moderate        Severe        Very Severe 
Difficulty falling asleep:     0               1                  2                   3                      4 
Difficulty staying asleep:     0               1                  2                   3                      4 
Problem waking up too early:   0               1                  2                   3                      4 
 
 
2. How SATISFIED/dissatisfied are you with your current sleep pattern? 
  
         Very                   Satisfied                 Neutral              Dissatisfied                 Very         
        Satisfied                                                                                                        Dissatisfied 
              0                            1                            2                            3                            4 
 
3. To what extent do you consider your sleep problem to INTERFERE 
with your daily functioning (e.g. daytime fatigue, ability to function at 
work/daily chores, concentration, memory, mood, etc.). 
 
           
    Not at all                A Little               Somewhat                 Much                Very Much 
   Interfering                                                                                                        Interfering 
            0                            1                            2                            3                             4 
 
4. How NOTICEABLE to others do you think your sleeping problem is 
in terms of impairing the quality of your life? 
 
    Not at all                A Little               Somewhat                 Much                Very Much 
   Noticeable                                                                                                       Noticeable   
             0                            1                            2                            3                             4 
 
5. How WORRIED/distressed are you about your current sleep problem? 
 
    Not at all                A Little               Somewhat                 Much                Very Much 
    Worried                                                                                                           Worried 
            0                            1                            2                            3                             4 
  
 
 
 
 
 
 
 
© Morin, C.M. (1993).  Insomnia: Psychological Assessment and Management.  New York: Guilford 
Press. 
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APPENDIX G:  The Questionnaire on Stress in Cancer Patients-Revised 
 
 
 
 
Here is a list of situations that you might encounter and that might cause you stress. For each 
situation, please first decide whether the situation currently applies to you. If so, then please indicate 
how much of a problem the situation is for you by making an 'X' on the five point scale "only a 
slight problem" to "a very big problem". If not, then make an 'X' under "Does not apply to me". 
 
1. I often feel tired and weak.  ______________________________________________ □  □  □  □  □ 
2. I am suffering pain due to surgery.  ________________________________________ □  □  □  □  □ 
3. I feel unconfident in relationships with other people.  __________________________ □  □  □  □  □  
4. I am suffering pain due to unknown causes (headaches, lower back pain,  
    stomach aches).  _______________________________________________________ □  □  □  □  □ 
5. I am afraid of the progression of my disease.  ________________________________ □  □  □  □  □ 
6. Other people’s reactions are often inconsiderate/unsympathetic.  _________________ □  □  □  □  □ 
7. Body care has become difficult since I developed cancer.  ______________________ □  □  □  □  □ 
8. I am afraid of developing pain.  ___________________________________________ □  □  □  □  □ 
9. I feel I am of less value to other people.  ____________________________________ □  □  □  □  □ 
10. I am afraid of having to go to the hospital again.  ____________________________ □  □  □  □  □ 
11. I feel physically imperfect.  _____________________________________________ □  □  □  □  □ 
12. I cannot partake in my hobbies (e.g. sports) as much as before I developed cancer.  _ □  □  □  □  □ 
13. I often have trouble sleeping.  ___________________________________________ □  □  □  □  □ 
14. I am afraid of not being able to work anymore.  _____________________________ □  □  □  □  □ 
15. I do not feel well informed about my illness/treatment. _______________________ □  □  □  □  □ 
16. I am often tense and nervous.  ___________________________________________ □  □  □  □  □ 
17. I have had sex less frequently since developing cancer.  _______________________ □  □  □  □  □ 
18. I do not feel adequately informed about possibilities for social/financial support.  ___ □  □  □  □  □ 
19. It is difficult to talk with my family about my situation.  _______________________ □  □  □  □  □ 
Does not 
apply to me 
Only a 
slight 
problem 
A very big 
problem 
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APPENDIX G:  The Questionnaire on Stress in Cancer Patients (continued) 
 
 
 
 
 
20. Since I developed cancer I have been going out less (to the movies, out to eat,  
     visiting friends, etc.).  __________________________________________________ □  □  □  □  □ 
21. Different doctors gave different information about my illness.  __________________ □  □  □  □  □ 
22. I have too few opportunities to talk about emotional problems with a specialist.  ____ □  □  □  □  □ 
23. It is difficult for my spouse/partner to empathize with my situation.  ______________ □  □  □  □  □ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Herschbach 2001 
Does not 
apply to me 
Only a 
slight 
problem 
A very big 
problem 
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Table 1.  Diagnostic Criteria for Comorbid Insomnia 
 
 
 
 
General Criteria 
 
A.  Difficulty sleeping, characterized by either (or both) of the following: 
1.  Difficulty initiating sleep (>30 minutes to fall asleep) 
2.  Difficulty maintaining sleep (>30 minutes of nocturnal  
     awakenings) with corresponding sleep efficacy (ratio of total sleep time   
                 to time spent in bed) less than 85%. 
 
B.  Sleep disturbance occurs at least 3 nights per week. 
 
C.  Sleep disturbance causes significant impairment of daytime functioning (e.g. fatigue,  
      sleepiness) or marked distress. 
 
 
Duration Specifies 
A.  Transient or situational:  duration of 1 month or less 
 
B.  Short-term or subacute:  duration of more than 1 month and less than 6 months 
 
C.  Chronic:  duration of 6 months or more 
 
 
 
 
Adapted from: Savard, J., & Morin, C.M. (2001).  Insomnia in the context of cancer: A 
review of a neglected problem.  Journal of Clinical Oncology, 19, 895-908. 
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Table 2:  Inclusion and Exclusion Criteria 
 
                                                                                                                                                                                                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inclusion Criteria Exclusion Criteria 
· Be 18 years of age and older 
· Diagnosed and treated for cancer at 
The Cancer Institute of New Jersey 
at Cooper University Hospital 
· Do not have a current cancer 
diagnosis. 
· Been in remission for more than 
one year.  
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Table 3: Outline of Measures 
Appendix Name of Tool Source/ 
Year 
Purpose/Focus Number 
of Items 
Scaling/ 
Scoring 
Psychometric 
Properties 
A 
Acceptance 
and Action 
Questionnaire
-2 
Hayes et 
al. (2004) 
Investigate level 
of acceptance as 
a potential 
mediator 
between stress 
and sleep. 
10 
7 point 
scale 
Cronbach’s α 
= .70; does 
not have 
published 
validity and 
reliability 
information to 
date 
B 
Descriptive 
Information 
Form 
N/A 
Obtain 
demographic 
information that 
may be 
predisposing 
factors 
18 
Mixed 
format N/A 
C 
Dysfunctional 
Beliefs and 
Attitudes 
about Sleep-
Short Form 
Edinger et 
al., 2001; 
Morin, 
1993 
Identify 
perpetuating 
factors, that 
being beliefs and 
attitudes about 
sleep. 
10 
Visual 
analog 
scale  
Cronbach’s  α  
= .81; 
reliability = 
.58 to .79 
D 
Five Facet 
Mindfulness 
Questionnaire 
Baer et al., 
2006 
Evaluate 
mindfulness as a 
potential 
mediator 
between stress 
and sleep. 
39 
5 point 
scale/five 
subscale ( 
nonreactivit
y, 
observing, 
acting with 
awareness, 
describing, 
& 
nonjudgme
nt 
Cronbach’s  α  
= .75-.91 
E 
Hospital 
Anxiety and 
Depression 
Scale 
Zigmond 
& Snaith, 
1983;  
Bjelland et 
al., 2002 
Investigate levels 
of anxiety and 
depression as 
predisposing 
factors. 
14 
5 point 
scale /two 
subscales 
(anxiety 
and 
depression) 
HADS-A  
Cronbach’s  α  
=  .68 to .93; 
HADS-D  
Cronbach’s  α  
=  .67 to .90 
F 
Insomnia 
Severity 
Index 
Bastien, 
Vallieres, 
& Morin, 
2001; 
Morin, 
1993 
Assess severity 
of symptoms 
associated with 
insomnia. 
7 5 point 
scale 
Cronbach’s  α  
= .74 
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Table 3: Outline of Measures (continued)  
Appendix Name of Tool Source/ 
Year 
Purpose/Focus Number 
of Items 
Scaling/ 
Scoring 
Psychometric 
Properties 
G 
Questionnaire 
on Stress in 
Cancer 
Patients - 
Revised 
 
Herschbac
h, Keller, 
Knight, 
Brandi, 
Huber, 
Henrich, 
& Marten-
Mittag, 
2004 
Evaluate stress 
specific to cancer 
as a precipitating 
factor. 
23 5 point 
scale 
Cronbach’s  α  
=  .89  
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Table 4. Demographic Variables for Sample 
 
 
 
 
Demographic Variables     Number of Subjects   %                    
 
Ethnic Identity 
 Caucasian     41   73.2 
 African American    10   17.9 
 Native American    3   5.4  
  
Hispanic     1   1.8 
 Other      10   8.8 
 
Marital Status 
 Single      3   5.4 
 Married     36   64.3 
 Separated     1   1.8 
Divorced     6   10.7 
 Widowed     5   8.9 
 In a Significant Relationship   5   8.9 
 
  
Children 
 Yes      45   80.4 
 No      11   19.6 
 
Education Level 
 High School     14   25 
 Trade School     1   1.8 
 Some College     13   23.2 
 Graduated College (2 year)   1   1.8 
 Graduated College (4 year)   17   30.4 
 Graduate School (Masters)   7   12.5 
 Graduate School (Doctorate)   3   5.4 
 
Employment      
 Full Time     26   46.4 
 Part Time     5   8.9 
 Homemaker     6   10.7 
 Retired     10   17.9 
 Unemployed     8   14.3 
 Other      1   1.8 
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Table 4. Demographic Variables for Sample (continued) 
 
 
 
 
Demographic Variables     Number of Subjects   %                    
 
Stage of Cancer 
 Stage I or IA     11   20.4 
 Stage II or IIA     16   29.6 
 Stage IIB     3   5.6 
 Stage III or IIIA    11   20.4 
 Stage IIIB     2   3.7 
 Stage IIIC     1   1.9 
 Stage IV     10   18.5 
 Missing     1   1.8 
 
Metastatic Disease 
 Yes      10   18.5 
 No      35   64.8 
 I don’t know     9   16.7 
 
Radiation Treatment 
 Yes      34   60.7 
 No      22   39.3 
 
Chemotherapy  Treatment      
 Yes      55   98.2 
 No      1   1.8 
 
Hormone Treatment 
 Yes      16   28.6 
 No      40   71.4 
 
Surgical Treatment 
 Yes      31   55.4 
 No      25   44.6 
 
Receiving Psychological Treatment 
 Yes      12   22.2 
 No      42   77.8 
 
Mean Age  =  50.61 (SD = 11.28) 
Age 26-40 [n=10]; Age 41-60 [n=34]; Age 61-75 [n=12] 
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Table 5: Sample Means Compared to Published Means 
 
 
Variable    Sample Mean and           Normative Mean and        T-test 
    Standard Deviation          Standard Deviation  
 
Acceptance and Action Questionnaire2    
 Total   M =  53.28 (8.93)  M = 50.72 (9.19)  t(53) = 2.10* 
 
Dysfunctional Beliefs and Attitudes  
about Sleep-Short Form3  M =  49.75 (19.09)             M =  44.12 (14.74) †    t(55) = 2.21* 
                 M =  27.74 (17.31) ††  t(55) = 8.63** 
 
Five Facet Mindfulness Questionnaire4    
Total Score (Community) M =  133.54 (16.72)            M = 116.9†  t(53) = 7.31** 
 Total Score (Educated) M =  133.54 (16.72)            M = 137.32††  t(53) = -1.66 
 
Hospital Anxiety and Depression Scale5    
 Anxiety    M = 6.83 (3.92)             M =6.14 (3.76)           t(53) = 1.30 
 Depression   M = 4.04 (3.55)            M =3.68 (3.07)              t(55) = .75 
   
Insomnia Severity Index 
Cancer Sample6  M = 9.04 (6.56)  M = 8.7 (6.8)           t(55) =  .38 
Sleep Disorder Sample7 M = 9.04 (6.56)  M = 19.70 (4.1)          t(55) = -12.16** 
 
Questionnaire on Stress in Cancer  
Patients- Revised8   M =  1.85 (.65)  M = 1.32 (.85)         t(50)= 5.82**  
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
2 Bond et al., Submitted.  Means based on student and community sample. 
3 Rumble et al. 2005. Means are based on:  insomnia group†  comparison group††  
4 Bear et al., 2008.  Means are based on  nonclinical: community sample †  educated group†† 
5 Crawford et al., 2001.  Means are based on non-clinical sample. 
6 Savard et al., 2005.  Means are based on female cancer patients. 
7 Bastien et al., 2001.  Means are based on sleep disorder patients. 
8 Herschbach et al., 2004.  Means are based on female cancer patients. 
*p<.05, **p<.01 
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Table 6: Cronbach’s Alpha for Primary Measures 
 
 
 
Variable      Cronbach’s Alpha 
Acceptance and Action Questionnaire-29    .79 
Dysfunctional Beliefs and Attitudes about Sleep-Short Form10 .81 
Five Facet Mindfulness Questionnaire11    .86 
Nonreactivity 
Observing 
Acting with awareness 
Describing 
Nonjudgment 
 
Hospital Anxiety and Depression Scale12 
 Anxiety       .87 
 Depression       .82 
 
Insomnia Severity Index13      .91 
 
Questionnaire on Stress in Cancer Patients – Revised14  .91 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
9 AAQ-2 (Bond et al., submitted) 
10 DBAS (Morin, 1993) 
11 FFMQ (Bear et al., 2006; Bear et al., 2008) 
12 HADS (Zigmond & Snaith, 1983) 
13 ISI (Bastien, Vallieres, & Morin, 2001) 
14 QSCP-R (Herschbach et al., 2004) 
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Table 7: Interrelationship between Primary Measures 
 
 
 
 
 
 
 
                                                 
15 Insomnia Severity Index (Bastien, Vallieres, & Morin, 2001) 
16Questionaire on Stress in Cancer Patients - Revised (Herschbach et al., 2004)  
17Dysfunctional Beliefs and Attitudes about Sleep-Short Form(Edinger et al., 2001; Morin, 1993)  
18 Hospital Anxiety and Depression Scale - Depression Subscale (Zigmond & Snaith, 1983) 
19 Hospital Anxiety and Depression Scale - Anxiety Subscale (Zigmond & Snaith, 1983) 
20 Five Facets of Mindfulness Questionnaire (Bear et al., 2006; Bear et al., 2008) 
21 Acceptance and Action Questionnaire-2 (Bond et al., submitted) 
  
Outcome Precipitating Factors 
Perpetuating 
Factors 
Predisposing 
Factors 
Moderating 
Factors 
 Scale 
Insomnia 
Symptoms 
r,p 
Cancer 
Specific 
Stress 
r,p 
Beliefs and 
Attitudes 
about Sleep 
r,p 
Depression 
r,p 
Anxiety 
r,p 
Mindfulness 
r,p 
Acceptance 
r,p 
O
ut
co
m
e 
Insomnia 
Symptoms15 - - - - - - - 
Pr
ec
ip
ita
tin
g 
Fa
ct
or
s Cancer 
Specific 
Stress16 
.66, 
<.001** - - - - - - 
Pe
rp
et
ua
tin
g 
Fa
ct
or
s Beliefs and 
Attitudes 
about 
Sleep17 
.40,  
.002** 
.45,  
.001** 
- - - - - 
Pr
ed
is
po
si
ng
 
Fa
ct
or
s 
Depression
18 
.28,  
.037* .54, <.001** 
.29,  
.029* - - - - 
Anxiety19 .43,  
.001** 
.58, <.001** .31,  
.022* 
.34,  
.011* 
- - - 
M
od
er
at
in
g 
Fa
ct
or
s 
Mindfulnes
s20 
-.10,  
.462 
-.20,  
.157 
.02,  
.866 
-.34,  
.012* 
-.50, 
<.001** - - 
Acceptance
21 
-.34,  
.01* 
-.05, 
<.001** 
-.26,  
.06 
-.42, 
 .002** 
-.67, 
<.001** 
.56, 
<.001** - 
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Table 8. Means on Insomnia Severity Index by Type of Cancer 
 
 
 
 
Symptoms of Insomnia22 
    M  SD   
Breast Cancer   9.04  6.56 
 
Colon Cancer   7.60  4.86 
 
Gynecologic Cancer  9.05  6.89 
 
Liver Cancer   4.00  (N/A)† 
 
Lung Cancer   9.08  6.69 
 
Lymphoma   12.60  2.88 
 
Prostate Cancer  8.00  7.81 
 
†not included in analysis because n=1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
22 ISI (Bastien, Vallieres, & Morin, 2001) 
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Table 9. Results from Simultaneous Entry Linear Regressions (Aim II) 
 
 
 
Symptoms of Insomnia23 
     R² F B SE Beta  t p   
 
Independent Variables 
 Surgery      1.99 1.48 .16 1.35 .185 
Anxiety24     .23 .21 .14 .14 .293 
 Depression25     .27 .24 .14 1.14 .260 
 Age      -.02 .07 -.03 -.28 .779 
 History of Sleep Difficulties   6.17 1.65 .47 3.75 <.001**  
      
.42 6.75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
23 ISI (Bastien, Vallieres, & Morin, 2001) 
24 HADS Anxiety Subscale (Zigmond & Snaith, 1983) 
25 HADS Depression Subscale (Zigmond & Snaith, 1983) 
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Table 10. Results from Hierarchical Regressions (Aim III) 
 
 
 
Symptoms of Insomnia26 
     R² F B SE Beta  t p   
Step 1: Covariate 
 Surgery      .51 .25 .28 2.03 .048* 
     .08 4.10 
      
 
Step 2: Predisposing Factors 
 Surgery      .34 .22 .19 1.57 .123 
 History of Sleep Difficulties   1.00 .23 .52 4.31 <.001*  
    .34         12.08 
 
Step 3: Precipitating Factors 
 Surgery      .10 .19 .05 .50 .62 
 History of Sleep Difficulties   .65 .21 .34 3.09 .003** 
  
 Cancer Specific Stress27    .71 .16 .51 4.49 <.001** 
                                                          .54 18.07 
Note. ΔR2=.26 for Step 2; ΔR2=.20 for Step 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
26 ISI (Bastien, Vallieres, & Morin, 2001) 
27 QSCP-R (Herschbach et al., 2004) 
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Table 11. Results from Hierarchical Regressions (Aim IV) 
 
 
 
Symptoms of Insomnia28 
     R² F B SE Beta  t p   
Step 1: Covariate 
 Surgery      .52 .24 .29 2.15 .036** 
  
 Marital Status     .18 .08 .29 2.19 .034** 
  
 .16 4.60 
 
Step 2: Predisposing Factors 
 Surgery      .37 .22 .20 1.68 .099 
  
 Marital Status     .11 .08 .17 1.40 .169 
 History of Sleep Difficulties   .92 .24 .47 3.84 <.001** 
.408 .87 
 
Step 3: Precipitating Factors 
 Surgery      .11 .20 .06 .56 .58 
Marital Status     .03 .07 .05 .44 .66 
 History of Sleep Difficulties   .64 .22 .33 2.96 .005** 
 Cancer Specific Stress29    .69 .17 .50 4.17 <.001** 
     .54 13.37 
 
Step 3: Perpetuating Factors 
 Surgery      .10 .20 .06 .52 .604 
Marital Status     .03 .07 .04 .36 .719 
 History of Sleep Difficulties   .63 .22 .33 2.90 .006** 
 Cancer Specific Stress30    .68 .18 .50 3.88 <.001** 
 Dysfunctional Beliefs and  
Attitudes about Sleep31    .00 .00 .03 .25 .801 
     .54 10.48      
Note. ΔR2=.20 for Step 2; ΔR2=.18 for Step 3; ΔR2=.001 for Step 3. 
 
 
 
 
 
 
 
 
 
 
                                                 
28 ISI (Bastien, Vallieres, & Morin, 2001) 
29 QSCP-R (Herschbach et al., 2004) 
30 QSCP-R (Herschbach et al., 2004) 
31 DBAS (Morin, 1993) 
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Table 12. Results from Simultaneous Entry Linear Regressions (Hypothesis 5a) 
 
 
 
Symptoms of Insomnia32 
     R² F B SE Beta  t p   
Surgery       1.02 1.57 .08 .65 .52 
Acceptance 33†      -.01 .11 -.01 -.05 .96 
Cancer specific stress34†     6.15 1.46 .60 4.22 <.001 
(Cancer specific stress†) X (Acceptance†)   -.06 .12 -.07 -.53 .60  
     .43 8.44 
†Centered Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
32 ISI (Bastien, Vallieres, & Morin, 2001) 
33 AAQ-2 (Bond et al., submitted)  
34 QSCP-R (Herschbach et al., 2004) 
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Table 13. Results from Simultaneous Entry Linear Regressions (Hypothesis 5b) 
 
 
 
Symptoms of Insomnia35 
     R² F B SE Beta  t p   
Surgery       1.13 1.54 .09 .73 .47 
Mindfulness36†      .04 .05 .10 .83 .41 
Cancer specific stress37†     6.59 1.22 .65 5.39 <.001 
(Cancer specific stress†) X (Mindfulness†)   .09 .09 .12 1.03 .31  
     .44 8.97 
†Centered Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
35 ISI (Bastien, Vallieres, & Morin, 2001) 
36 FFMQ (Bear et al., 2006; Bear et al., 2008)  
37 QSCP-R (Herschbach et al., 2004) 
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Table 14. Results from Simultaneous Entry Linear Regressions (Hypothesis 6a) 
 
 
 
Symptoms of Insomnia38 
     R² F B SE Beta  t p   
Surgery       2.13 1.63 .16 1.31 .20 
Marital Status      .47 .57 .11 .83 .41 
Acceptance 39†      -.01 .26 -.01 -.02 .98 
Dysfunctional Beliefs about Sleep40†   .01 .01 .31 2.24 .03 
(Dysfunctional Beliefs about Sleep†) X (Acceptance†) .00 .00 -.24 -.69 .49  
     .29 3.98 
†Centered Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
38 ISI (Bastien, Vallieres, & Morin, 2001) 
39 AAQ-2 (Bond et al., submitted) 
40 DBAS-SF(Edinger et al., 2001; Morin, 1993)  
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Table 15. Results from Simultaneous Entry Linear Regressions (Hypothesis 6b) 
 
 
 
Symptoms of Insomnia41 
     R² F B SE Beta  t p   
Surgery       2.46 1.67 .19 1.48 .15 
Marital Status      .60 .61 .14 .99 .33 
Mindfulness42†      .23 .15 .58 1.49 .14 
Dysfunctional Beliefs about Sleep43†   .01 .01 .33 2.31 .03 
(Dysfunctional Beliefs about Sleep†)  
X (Mindfulness†)      .00 .00 -.69 -1.74 .09  
     .27 3.48 
†Centered Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
41 ISI (Bastien, Vallieres, & Morin, 2001) 
42 FFMQ (Bear et al., 2006; Bear et al., 2008) 
43 DBAS-SF(Edinger et al., 2001; Morin, 1993)  
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Table 16. Descriptive Statistics by Type of Cancer: 
 Questionnaire on Stress in Cancer Patients – Revised Version 
  
 
 
 
 
Cancer Specific Stress44 
    M  SD   
Breast Cancer   1.84  .65 
 
Colon Cancer   2.02  .94 
 
Gynecologic Cancer  1.84  .59 
  
Liver Cancer   1.26  (N/A)† 
 
Lung Cancer   1.74  .61 
 
Lymphoma   2.03  .64 
 
Prostate Cancer  1.81  .81 
 
†not included in analysis because n=1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
44 QSCP-R (Herschbach et al., 2004) 
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*Found to be significant in present study 
 
 
 
 
 
 
 
 
 
Figure 1:  Proposed Three-factor Model of Insomnia in relation to Breast Cancer 
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Figure 2: Distribution of Insomnia Severity Index Scores45 
 
 
 
 
 
 
                                                 
45 ISI (Bastien, Vallieres, & Morin, 2001) 
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Figure Captions 
 
 
Figure 1.  Proposed Three-factor Model of Insomnia in relation to Breast Cancer 
    Adapted from:  Savard, & Morin. (2001); Spielman et al., (1987); Spielman &   
    Glovinsky. (1991) 
 
Figure 2:  Distribution of Insomnia Severity Index Scores 
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